CA2223954C - Method and apparatus for accessing the pericardial space - Google Patents
Method and apparatus for accessing the pericardial space Download PDFInfo
- Publication number
- CA2223954C CA2223954C CA002223954A CA2223954A CA2223954C CA 2223954 C CA2223954 C CA 2223954C CA 002223954 A CA002223954 A CA 002223954A CA 2223954 A CA2223954 A CA 2223954A CA 2223954 C CA2223954 C CA 2223954C
- Authority
- CA
- Canada
- Prior art keywords
- tubular body
- outer tubular
- needle
- aperture
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/77—Suction-irrigation systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0587—Epicardial electrode systems; Endocardial electrodes piercing the pericardium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3468—Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3478—Endoscopic needles, e.g. for infusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00269—Type of minimally invasive operation endoscopic mucosal resection EMR
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22038—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/30—Surgical pincettes without pivotal connections
- A61B2017/306—Surgical pincettes without pivotal connections holding by means of suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B2017/348—Means for supporting the trocar against the body or retaining the trocar inside the body
- A61B2017/3482—Means for supporting the trocar against the body or retaining the trocar inside the body inside
- A61B2017/3484—Anchoring means, e.g. spreading-out umbrella-like structure
- A61B2017/3488—Fixation to inner organ or inner body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00392—Transmyocardial revascularisation
Abstract
This invention is a pericardial centesis apparatus (100) and method for accessing the pericardial space. The invention consists of inserting a percutaneous tube (104) whose tip has a hole (123) which is positioned over and contacts the anterior pericardium. Introducing a vacuum within said tube (104) forms a pericardial bleb within that hole. A guided needle (124) within the tube is advanced to puncture the pericardial bleb while avoiding contact with the epicardium. A hollow filame nt or electro-cardial lead or flexible guide wire (114) within said needle can then be advanced into said pericardial cavity. The guide wir e (114) may be used to guide an intra-pericardial catheter into the pericardial space for injection or infusion of selected therapeutic agents into the pericardial space to treat various heart and blood vessel diseases. Controlled drug release materials can be injected through said needle (124) for the slow and/or sustained delivery of said therapeutic agents into said pericardial cavity.
Description
METHOD AND APPARATUS FOR ACCESSING THE PERICARDIAL SPACE
Background Of The Invention This invention relates to methods and apparatus for accessing the pericardial space for medical treatment of the heart.
5- Knowledge of the pericardium dates back to the time of Galen (129-200 A.D.) the Greek physician and anatomist who gave the pericardium its name. The pericardial sac surrounds the heart like a glove enfolds a hand, and the pericardial space is naturally fluid-filled. The normal pericardium functions to prevent dilatation of the chambers of the heart, lubricates the surfaces of the heart, and maintains the heart in a fixed geometric position. It also provides a barrier to the spread of infection from adjacent structures in the chest, and prevents the adhesion of surrounding tissues to the heart. See generally, Holt JP: The normal pericardium, Amer J Cardiol 26:455,1970; Spodick DH.= Medical history of the pericardium, Amer J Cardiol 26: 447,1970. The normal pericardial space is small in volume and the fluid film within it is too thin to functionally separate the heart from the pericardium. It has been observed that when fluid is injected into the pericardial space it accumulates in the atrioventricular and interventricular grooves, but not over the ventricular surfaces[Shabetai R:
Pericardial and cardiac pressure, Circulation 77:1, 1988J.
Pericardiocentesis, or puncture of the pericardium, heretofore has been indicated for (1) diagnosis of pericardial disease(s) by study of the pericardial fluid, (2) withdrawal of pericardial fluid for the treatment of acute cardiac tamponade, and (3) infusion of therapeutic agents for the treatment of malignant effusion or tumors. During 1994, it is estimated that approximately 12,000 pericardiocentesis procedures were performed in the United States and that less than 200 of these patients underwent therapy with the intrapericardial injection of drugs. At present, intrapericardial injection of drugs is clinically limited to the treatment of abnormal pericardial conditions and diseases, such as malignant or loculated pericardial effusions and tumors. Drugs that have been injected into the pericardial space include antibiotic (sclerosing) agents [Wei J, et al: Recurrent cardiac tamponade and large pericardial = effusions: Management with an indwelling pericardial catheter, Amer J
Cardiol 42:281,1978;
Davis S, et al: Intrapericardial tetracycline for the management of cardiac tamponade secondary to malignant pericardial effusion, N Engl J Med 299:1113,1978;
Shepherd F, et al:
Tetracycline sclerosis in the management of malignant pericardial effusion, J
Clin Oncol SUBSTITUTE SHEET (RULE 26) 3:1678,1985; Maher E, et al: Intraperi-cardial instillation of bleomycin in malignant pericardial effusion, Amer Heart J 11:613,1986; van der Gaast A, et al.-Intrapericardial instillation of bleomycin in management of malignant pericardial effusion, Eur J Cancer Clin Oncol 25:1505,1989; Imamura T, et al: Intrapericardial instillation of OK-432 for the management of malignant pericardial effusion, Jpn J Med 28: 62,1989; Cormican M, et al: =
Intraperi-cardial bleomycin for the management of cardiac tamponade secondary to malignant pericardial effusion, Brit Heart J 63:61,1990; Mitchell M, et al: Multiple myeloma complicated by restrictive cardiomyopathy and cardiac tamponade, Chest 103:946, 19931, antineoplastic drugs [Terpenning M, et a1: Intrapericardial nitrogen mustard with catheter drainage for the treatment of malignant effusions, Proc Amer Assoc Cancer Res (abstr) 20:286,1979; Markman M, et al.- Intrapericardial instillation of cisplatin in a patient with a large malignant effusion, Cancer Drug Delivery 1:49,1985; Figoli F, et al.- Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effitsion, Cancer Chemotherapy Pharmacol 20:239, 1987; Fiorentino M, et a1: Intrapericardial instillation of platin in malignant peri-cardial effusion, Cancer 62:1904,1988], radioactive compound [Martini N, et al: Intra-pericardial instillation of radioactive chronic phosphate in malignant pericardial effusion, AJR 128:639,1977], and a fibrinolytic agent [Cross J, et al: Use of streptokinase to aid in drainage of postoperative pericardial effusion, Brit Heart J
62: 217,1989J.
Intrapericardial drug delivery has not been clinically utilized for heart-specific treatments where pericardial pathology is normal, because the pericardial space is normally small and very difficult to access without invasive surgery or risk of cardiac injury by standard needle pericardiocentesis techniques. The pericardiocentesis procedure is carried out by experienced personnel in the cardiac catheterization laboratory, with equipment for fluoroscopy and monitoring of the electrocardiogram. Electrocardiographic monitoring of the procedure using the pericardial needle as an electrode is commonly employed [Bishop LH, et al: The electrocardiogram as a safeguard in pericardiocentesis, JAMA 162: 264,1956,=
Neill JR, et al:
A pericardiocentesis electrode, N Engl J Med 264:711,1961; Gotsman MS, et al:
A
pericardiocentesis electrode needle, Br Heart J 28: 566,1966,= Kerber RE, et al.=
Electrocardiographic indications of atrial puncture during pericardiocentesis, N Engl J Med 282:1142,19701. An echocardiographic transducer with a central lumen has also been used to guide the pericardiocentesis needle [Goldberg BB, et al: Ultrasonically guided pericardiocentesis, Amer J Cardiol 31:490,1973]. Complications associated with needle SUBSTITUTE SHEET (RULE 26) pericardiocentesis include laceratioti of a coronary artety or the right ventricle, perforation of the right atrium or ventricle, puncture of the stomach or colon, pneumothorax, arrhythmia, tamponade, hypotension, ventricular fibrillation, and death. The complication rates for needle = pericardiocentesis are increased in situations where the pericardial space and fluid effusion volume is small (i.e., the pericardial size is more like normal).
Chin et al have described a method and apparatus for accessing the pericardial space for the insertion of implantable defibrillation leads[U.,S. Patent No.
5,071,428]. The method required gripping the pericardium with a forceps device and cutting the pericardium with a scalpel (pericardiotomy) under direct vision through a subxiphoid surgical incision.
A method for the intrapericardial injection of angiogenic agents has been reported [Uchida Y, et al: Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparan sulfate, Circulation AHA Abstracts -19941. While the method was not described in detail, it generally involved the percutaneous transcatheter bolus injection of drugs into the pericardial cavity via the right atrium. The major limitation of this method is that the right atrial wall is crossed which could lead to bleeding into the pericardial space. In addition, the method involved the bolus injection of drugs rather than long-term delivery via a catheter or controlled release material.
Summary Of The Invention A principal object of the invention is to provide a method and apparatus for accessing the pericardial space without invasive surgery and to reduce the risk of injury to the heart during pericardial catheterization.
A more specific object of the invention is to provide an apparatus with the means to create a needle puncture through the wal l of the pericardium without puncture of the heart.
A further object of the invention is to provide an apparatus with a lumen to be used for the introduction of other elements and materials into the pericardium for site-specific drug delivery to the heart and coronary arteries, or the introduction of implantable defibrillator or other cardioregulatory electrodes into the pericardial space.
= Still another object of the invention is to provide a method for advancing a catheter into the pericardial space for the withdrawal of pericardial fluid and/or the intrapericardial injection or infusion of bioactive therapeutic agents to treat diseases of the heart and coronary arteries.
SUBSTITUTE SHEET (RULE 26) Yet another object of the invention is to provide an apparatus having a simple mode of operation which may be used to pass a guide wire and catheter into the pericardial space without the need for invasive surgery.
The present invention provides apparatus and method for nonsurgical access to the pericardial space through a needle puncture of the anterior pericardium (pericardiocentesis) in a manner reducing risk of injury to the heart, provides a lumen for introduction of substances into the pericardial space through the pierced pericardium, and allows introduction of a catheter into the pericardial space so accessed, thereby to enable the withdrawal of pericardial fluid and/or the intrapericardial injection or infusion of bioactive therapeutic agents to treat diseases of the heart and coronary arteries in a site specific manner, or to allow the introduction of implantable defibrillator electrodes into the pericardial space.
An apparatus of the present invention for percutaneously accessing the intrapericardial space comprises an elongated outer tubular body having a closed distal end, an aperture in a sidewall adjacent the closed end, and a proximal portion for applying a vacuum thereto. An elongated inner tubular body has a distal end sealingly extending into the outer tubular body from a proximal end external to the outer tubular body, creating a first passage between the first and inner tubular bodies. A piercing body is disposed in a distal portion of the outer tubular body adjacent the aperture. The piercing body has a sharp distal end and a lumen extending through it from a proximal end of it to a sidewall opening in it adjacent such sharp distal end.
The proximal end of the piercing body is connected to the distal end of the inner tubular body, thereby creating a conduit leading from outside the outer tubular body to the piercing body sidewall opening. The piercing body is longitudinally moveable in the outer tubular body to an extent permitting the distal end of the piercing body to traverse the aperture of the outer tubular body and appose the sidewall opening of the piercing body and the aperture of the outer tubular body. Means providing a passage are laterally adjacent the piercing body for permitting flow communication from the aperture of the outer tubular body to the passage between the tubular bodies, under influence of an applied vacuum, regardless of the longitudinal location of the piercing body in the distal portion of the outer tubular body.
The invention further constitutes a method for accessing a pericardial space, which comprises percutaneously inserting the distal portion of an elongated outer tubular body containing an aperture in a sidewall adjacent the distal end, locating such distal portion over the pericardium substantially parallel thereto with the aperture facing the pericardium surface, SUBSTITUTE SHEET (RULE 26) applying a vacuum to the tubular body remotely from the distal portion to draw a portion of the pericardium away from the surface of the heart into the aperture in a capture position, advancing a piercing element contained in the tubular body adjacent the aperture in a direction substantially parallel to the heart to pierce the portion of the pericardium captured in the opening, and retracting the piercing element to leave a hole in the pericardium.
The method of this invention further includes delivering a substance through the tubular body and into the pericardial space through the hole created in the pericardium. The substance suitably may be formed or formless. Suitably a formed substance is the distal portion of a filament. The filament may be electro- or photo-conductive, for example, a defibrillator electrode; it may be solid, such as a guidewire; or it may be hollow, such as a catheter.
Alternatively the substance may be formless, such as a liquid, paste or gel, and may be bioactive as a cardiovascular drug.
Where the substance is a filament, the method further comprises withdrawing the tubular body and the piercing body over the filament, leaving the filament distal portion in place in the pericardial space with a proximal portion inclusive of the proximal end of the filament remaining external to the body of the patient. Where the filament is electro-or photo-conductive, the invention further comprises accessing the proximal portion of the filament to regulate the heart. Where the filament is hollow, this method thereby provides an indwelling catheter to the pericardial space.
This invention suitably employs an elongated inner tubular body having a distal end sealingly extending into the percutaneously inserted outer tubular body from a proximal end external to the outer tubular body. The piercing element suitably comprises a body having a sharp distal end and a lumen extending therethrough from a proximal end thereof to a sidewall opening therein adjacent such sharp distal end, the proximal end of the piercing body being connected to the distal end of the inner tubular body, thereby creating a conduit leading from externally of the outer tubular body to the piercing body sidewall opening, the piercing body being longitudinally moveable in the outer tubular body to an extent permitting the distal end thereof to traverse the aperture and appose the piercing body sidewall opening and the aperture.
= In this embodiment, the substance is delivered through the so provided conduit into the pericardial space through the hole created in the pericardium.
In this latter aspect, where the substance is the distal portion of a filament, the step of delivering comprises advancing a filament distal portion through the inner tubular body and SUBSTITUTE SHEET (RULE 26) through the pericardium portal into the pericardial space.
Where the filament is a guidewire, the method of this invention further comprises withdrawing the first and inner tubular bodies and the piercing body over the guidewire, leaving the distal portion of said guidewire in place in the pericardial space, advancing the leading end of a catheter over said guidewire into said pericardial space, and then withdrawing said guidewire to leave said catheter end in said pericardial space. A bioactive substance may then be delivered into the pericardial space through this catheter.
Preferably the distal end of the tubular body is radio-opaque. Suitably the apparatus further comprises an electroconductive terminal adjacent said aperture and a terminal lead electroconductively communicating said terminal exteriorly of outer tubular body remotely from said distal end of said outer tubular body.
According to one aspect of the invention, there is provided an apparatus for percutaneously accessing the intrapericardial space, comprising : an outer elongated tubular body having a lumen, a distal portion including a closed distal end, an aperture in a sidewall adjacent the closed end, and a proximal portion for applying a vacuum thereto, an inner elongated tubular body having a lumen and a distal end sealingly extending into said outer tubular body lumen from a proximal end external to said outer tubular body, creating a first passage between said outer and inner tubular bodies, a piercing body disposed in said distal portion of said outer tubular body adjacent said aperture, said piercing body having a sharp distal end and a lumen extending therethrough from a proximal end thereof to a sidewall opening therein adjacent - 6a -such sharp distal end, the proximal end of said piercing body being connected to the distal end of said inner tubular body, thereby creating a conduit leading from externally of said outer tubular body through said lumen of said inner tubular body and said lumen of said piercing body to said piercing body sidewall opening, said piercing body being longitudinally moveable in said outer tubular body to an extent permitting the distal end thereof to traverse said aperture and appose said piercing body sidewall opening and said aperture, and passage means laterally adjacent said piercing body permitting flow communication from said aperture to said first passage regardless of the longitudinal location of said piercing body in said distal portion of said outer tubular body.
According to another aspect of the invention, there is provided an apparatus for percutaneously accessing the intrapericardial space, comprising: an elongate outer tubular body having a lumen, a distal portion including a closed distal end, and a passage extending through said body from an aperture in the sidewall of the body adjacent said distal end thereof and including a proximal portion for applying a vacuum, a needle having a sharp leading end, a trailing end and a lumen therethrough from said trailing end to a side opening in the needle adjacent said leading end, said needle being arranged in said tubular body to allow flow communication in said passage from said aperture toward said proximal opening under influence of an applied vacuum and being longitudinally moveable in said passage for said sharp end to traverse said aperture and appose said needle side opening and said aperture without occluding flow communication in said passage, and a filament received in said needle lumen and exiting said tubular body at a proximal portion thereof.
- 6b -According to still another aspect of the invention, there is provided an apparatus for percutaneously accessing the intrapericardial space, comprising: an elongated outer tubular body having a lumen, a closed distal end, an aperture in a sidewall adjacent the closed end, a proximal inlet and a proximal branch for applying a vacuum thereto, a seal in said proximal inlet for sealing said outer tubular body to maintain an applied vacuum in said outer tubular body, a needle carrier arranged and moveable longitudinally in a distal portion of said outer tubular body without occluding flow communication from said aperture toward said branch under influence of an applied vacuum, limiter means in said outer tubular body distally of said branch and proximately of said closure for limiting distal and proximal longitudinal travel of said needle car-rier, a needle having a lumen and carried in said needle carrier, said needle having a sharp leading end extending distally from said carrier and a trailing end extending proximately from said carrier, and having an opening adjacent said sharp leading end alignable with said aperture of said outer tubular body, an inner tubular body having a lumen and received in said outer tubular body lumen without occluding fluid flow therein under influence of an applied vacuum, and connected distally to said trailing end of said needle to provide a conduit including said needle lumen and said inner tubular body lumen, said inner tubular body sealingly exiting said outer tubular body proximately through said seal, and a filament received in said conduit.
According to yet another aspect of the invention, there is provided a use of the apparatus as defined herein, for accessing a pericardial space.
- 6c -According to yet another aspect of the invention, there is provided a use of the apparatus as defined herein, for accessing a pericardial space, wherein the distal end is adapted to be observed fluroscopically.
According to yet another aspect of the invention, there is provided a use of the apparatus as defined herein, for accessing a pericardial space, wherein the lead is adapted to monitor the electrocardial signal of a heart to determine contact of the aperture of said tubular body with a pericardium. body and for drawing a portion of a pericardium away from a heart surface; a piercing element contained in the tubular body adjacent said aperture, wherein said piercing element is for piercing said portion of said pericardium.
The nature, objects, and advantages of the present invention will become more apparent to those skilled in the art when viewed in light of the following detailed description and accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a longitudinal, centerline sectional, side-graphical outline or schematic view of the invention illustrating a preferred embodiment of the pericardiocentesis apparatus for nonsurgical intrapericardial access.
FIG. 2 is a side schematic view of the distal end portion of the invention.
FIG. 3 is a bottom schematic view of the distal end portion of the invention.
- 6d -FIG. 4 is a longitudinal, centerline sectional, side schematic view of the distal end of the invention.
FIG. 5 is a longitudinal, centerline sectional, side schematic view of the distal end of the invention showing the needle in the fully retracted (sheathed) position.
FIG. 6 is cross sectional view of Fig. 5, taken along the line 6-6 of FIG. 5.
FIG. 7 is a longitudinal, centerline sectional, side schematic of the distal end of the invention showing the needle in the fully advanced (extended) position.
Background Of The Invention This invention relates to methods and apparatus for accessing the pericardial space for medical treatment of the heart.
5- Knowledge of the pericardium dates back to the time of Galen (129-200 A.D.) the Greek physician and anatomist who gave the pericardium its name. The pericardial sac surrounds the heart like a glove enfolds a hand, and the pericardial space is naturally fluid-filled. The normal pericardium functions to prevent dilatation of the chambers of the heart, lubricates the surfaces of the heart, and maintains the heart in a fixed geometric position. It also provides a barrier to the spread of infection from adjacent structures in the chest, and prevents the adhesion of surrounding tissues to the heart. See generally, Holt JP: The normal pericardium, Amer J Cardiol 26:455,1970; Spodick DH.= Medical history of the pericardium, Amer J Cardiol 26: 447,1970. The normal pericardial space is small in volume and the fluid film within it is too thin to functionally separate the heart from the pericardium. It has been observed that when fluid is injected into the pericardial space it accumulates in the atrioventricular and interventricular grooves, but not over the ventricular surfaces[Shabetai R:
Pericardial and cardiac pressure, Circulation 77:1, 1988J.
Pericardiocentesis, or puncture of the pericardium, heretofore has been indicated for (1) diagnosis of pericardial disease(s) by study of the pericardial fluid, (2) withdrawal of pericardial fluid for the treatment of acute cardiac tamponade, and (3) infusion of therapeutic agents for the treatment of malignant effusion or tumors. During 1994, it is estimated that approximately 12,000 pericardiocentesis procedures were performed in the United States and that less than 200 of these patients underwent therapy with the intrapericardial injection of drugs. At present, intrapericardial injection of drugs is clinically limited to the treatment of abnormal pericardial conditions and diseases, such as malignant or loculated pericardial effusions and tumors. Drugs that have been injected into the pericardial space include antibiotic (sclerosing) agents [Wei J, et al: Recurrent cardiac tamponade and large pericardial = effusions: Management with an indwelling pericardial catheter, Amer J
Cardiol 42:281,1978;
Davis S, et al: Intrapericardial tetracycline for the management of cardiac tamponade secondary to malignant pericardial effusion, N Engl J Med 299:1113,1978;
Shepherd F, et al:
Tetracycline sclerosis in the management of malignant pericardial effusion, J
Clin Oncol SUBSTITUTE SHEET (RULE 26) 3:1678,1985; Maher E, et al: Intraperi-cardial instillation of bleomycin in malignant pericardial effusion, Amer Heart J 11:613,1986; van der Gaast A, et al.-Intrapericardial instillation of bleomycin in management of malignant pericardial effusion, Eur J Cancer Clin Oncol 25:1505,1989; Imamura T, et al: Intrapericardial instillation of OK-432 for the management of malignant pericardial effusion, Jpn J Med 28: 62,1989; Cormican M, et al: =
Intraperi-cardial bleomycin for the management of cardiac tamponade secondary to malignant pericardial effusion, Brit Heart J 63:61,1990; Mitchell M, et al: Multiple myeloma complicated by restrictive cardiomyopathy and cardiac tamponade, Chest 103:946, 19931, antineoplastic drugs [Terpenning M, et a1: Intrapericardial nitrogen mustard with catheter drainage for the treatment of malignant effusions, Proc Amer Assoc Cancer Res (abstr) 20:286,1979; Markman M, et al.- Intrapericardial instillation of cisplatin in a patient with a large malignant effusion, Cancer Drug Delivery 1:49,1985; Figoli F, et al.- Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effitsion, Cancer Chemotherapy Pharmacol 20:239, 1987; Fiorentino M, et a1: Intrapericardial instillation of platin in malignant peri-cardial effusion, Cancer 62:1904,1988], radioactive compound [Martini N, et al: Intra-pericardial instillation of radioactive chronic phosphate in malignant pericardial effusion, AJR 128:639,1977], and a fibrinolytic agent [Cross J, et al: Use of streptokinase to aid in drainage of postoperative pericardial effusion, Brit Heart J
62: 217,1989J.
Intrapericardial drug delivery has not been clinically utilized for heart-specific treatments where pericardial pathology is normal, because the pericardial space is normally small and very difficult to access without invasive surgery or risk of cardiac injury by standard needle pericardiocentesis techniques. The pericardiocentesis procedure is carried out by experienced personnel in the cardiac catheterization laboratory, with equipment for fluoroscopy and monitoring of the electrocardiogram. Electrocardiographic monitoring of the procedure using the pericardial needle as an electrode is commonly employed [Bishop LH, et al: The electrocardiogram as a safeguard in pericardiocentesis, JAMA 162: 264,1956,=
Neill JR, et al:
A pericardiocentesis electrode, N Engl J Med 264:711,1961; Gotsman MS, et al:
A
pericardiocentesis electrode needle, Br Heart J 28: 566,1966,= Kerber RE, et al.=
Electrocardiographic indications of atrial puncture during pericardiocentesis, N Engl J Med 282:1142,19701. An echocardiographic transducer with a central lumen has also been used to guide the pericardiocentesis needle [Goldberg BB, et al: Ultrasonically guided pericardiocentesis, Amer J Cardiol 31:490,1973]. Complications associated with needle SUBSTITUTE SHEET (RULE 26) pericardiocentesis include laceratioti of a coronary artety or the right ventricle, perforation of the right atrium or ventricle, puncture of the stomach or colon, pneumothorax, arrhythmia, tamponade, hypotension, ventricular fibrillation, and death. The complication rates for needle = pericardiocentesis are increased in situations where the pericardial space and fluid effusion volume is small (i.e., the pericardial size is more like normal).
Chin et al have described a method and apparatus for accessing the pericardial space for the insertion of implantable defibrillation leads[U.,S. Patent No.
5,071,428]. The method required gripping the pericardium with a forceps device and cutting the pericardium with a scalpel (pericardiotomy) under direct vision through a subxiphoid surgical incision.
A method for the intrapericardial injection of angiogenic agents has been reported [Uchida Y, et al: Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparan sulfate, Circulation AHA Abstracts -19941. While the method was not described in detail, it generally involved the percutaneous transcatheter bolus injection of drugs into the pericardial cavity via the right atrium. The major limitation of this method is that the right atrial wall is crossed which could lead to bleeding into the pericardial space. In addition, the method involved the bolus injection of drugs rather than long-term delivery via a catheter or controlled release material.
Summary Of The Invention A principal object of the invention is to provide a method and apparatus for accessing the pericardial space without invasive surgery and to reduce the risk of injury to the heart during pericardial catheterization.
A more specific object of the invention is to provide an apparatus with the means to create a needle puncture through the wal l of the pericardium without puncture of the heart.
A further object of the invention is to provide an apparatus with a lumen to be used for the introduction of other elements and materials into the pericardium for site-specific drug delivery to the heart and coronary arteries, or the introduction of implantable defibrillator or other cardioregulatory electrodes into the pericardial space.
= Still another object of the invention is to provide a method for advancing a catheter into the pericardial space for the withdrawal of pericardial fluid and/or the intrapericardial injection or infusion of bioactive therapeutic agents to treat diseases of the heart and coronary arteries.
SUBSTITUTE SHEET (RULE 26) Yet another object of the invention is to provide an apparatus having a simple mode of operation which may be used to pass a guide wire and catheter into the pericardial space without the need for invasive surgery.
The present invention provides apparatus and method for nonsurgical access to the pericardial space through a needle puncture of the anterior pericardium (pericardiocentesis) in a manner reducing risk of injury to the heart, provides a lumen for introduction of substances into the pericardial space through the pierced pericardium, and allows introduction of a catheter into the pericardial space so accessed, thereby to enable the withdrawal of pericardial fluid and/or the intrapericardial injection or infusion of bioactive therapeutic agents to treat diseases of the heart and coronary arteries in a site specific manner, or to allow the introduction of implantable defibrillator electrodes into the pericardial space.
An apparatus of the present invention for percutaneously accessing the intrapericardial space comprises an elongated outer tubular body having a closed distal end, an aperture in a sidewall adjacent the closed end, and a proximal portion for applying a vacuum thereto. An elongated inner tubular body has a distal end sealingly extending into the outer tubular body from a proximal end external to the outer tubular body, creating a first passage between the first and inner tubular bodies. A piercing body is disposed in a distal portion of the outer tubular body adjacent the aperture. The piercing body has a sharp distal end and a lumen extending through it from a proximal end of it to a sidewall opening in it adjacent such sharp distal end.
The proximal end of the piercing body is connected to the distal end of the inner tubular body, thereby creating a conduit leading from outside the outer tubular body to the piercing body sidewall opening. The piercing body is longitudinally moveable in the outer tubular body to an extent permitting the distal end of the piercing body to traverse the aperture of the outer tubular body and appose the sidewall opening of the piercing body and the aperture of the outer tubular body. Means providing a passage are laterally adjacent the piercing body for permitting flow communication from the aperture of the outer tubular body to the passage between the tubular bodies, under influence of an applied vacuum, regardless of the longitudinal location of the piercing body in the distal portion of the outer tubular body.
The invention further constitutes a method for accessing a pericardial space, which comprises percutaneously inserting the distal portion of an elongated outer tubular body containing an aperture in a sidewall adjacent the distal end, locating such distal portion over the pericardium substantially parallel thereto with the aperture facing the pericardium surface, SUBSTITUTE SHEET (RULE 26) applying a vacuum to the tubular body remotely from the distal portion to draw a portion of the pericardium away from the surface of the heart into the aperture in a capture position, advancing a piercing element contained in the tubular body adjacent the aperture in a direction substantially parallel to the heart to pierce the portion of the pericardium captured in the opening, and retracting the piercing element to leave a hole in the pericardium.
The method of this invention further includes delivering a substance through the tubular body and into the pericardial space through the hole created in the pericardium. The substance suitably may be formed or formless. Suitably a formed substance is the distal portion of a filament. The filament may be electro- or photo-conductive, for example, a defibrillator electrode; it may be solid, such as a guidewire; or it may be hollow, such as a catheter.
Alternatively the substance may be formless, such as a liquid, paste or gel, and may be bioactive as a cardiovascular drug.
Where the substance is a filament, the method further comprises withdrawing the tubular body and the piercing body over the filament, leaving the filament distal portion in place in the pericardial space with a proximal portion inclusive of the proximal end of the filament remaining external to the body of the patient. Where the filament is electro-or photo-conductive, the invention further comprises accessing the proximal portion of the filament to regulate the heart. Where the filament is hollow, this method thereby provides an indwelling catheter to the pericardial space.
This invention suitably employs an elongated inner tubular body having a distal end sealingly extending into the percutaneously inserted outer tubular body from a proximal end external to the outer tubular body. The piercing element suitably comprises a body having a sharp distal end and a lumen extending therethrough from a proximal end thereof to a sidewall opening therein adjacent such sharp distal end, the proximal end of the piercing body being connected to the distal end of the inner tubular body, thereby creating a conduit leading from externally of the outer tubular body to the piercing body sidewall opening, the piercing body being longitudinally moveable in the outer tubular body to an extent permitting the distal end thereof to traverse the aperture and appose the piercing body sidewall opening and the aperture.
= In this embodiment, the substance is delivered through the so provided conduit into the pericardial space through the hole created in the pericardium.
In this latter aspect, where the substance is the distal portion of a filament, the step of delivering comprises advancing a filament distal portion through the inner tubular body and SUBSTITUTE SHEET (RULE 26) through the pericardium portal into the pericardial space.
Where the filament is a guidewire, the method of this invention further comprises withdrawing the first and inner tubular bodies and the piercing body over the guidewire, leaving the distal portion of said guidewire in place in the pericardial space, advancing the leading end of a catheter over said guidewire into said pericardial space, and then withdrawing said guidewire to leave said catheter end in said pericardial space. A bioactive substance may then be delivered into the pericardial space through this catheter.
Preferably the distal end of the tubular body is radio-opaque. Suitably the apparatus further comprises an electroconductive terminal adjacent said aperture and a terminal lead electroconductively communicating said terminal exteriorly of outer tubular body remotely from said distal end of said outer tubular body.
According to one aspect of the invention, there is provided an apparatus for percutaneously accessing the intrapericardial space, comprising : an outer elongated tubular body having a lumen, a distal portion including a closed distal end, an aperture in a sidewall adjacent the closed end, and a proximal portion for applying a vacuum thereto, an inner elongated tubular body having a lumen and a distal end sealingly extending into said outer tubular body lumen from a proximal end external to said outer tubular body, creating a first passage between said outer and inner tubular bodies, a piercing body disposed in said distal portion of said outer tubular body adjacent said aperture, said piercing body having a sharp distal end and a lumen extending therethrough from a proximal end thereof to a sidewall opening therein adjacent - 6a -such sharp distal end, the proximal end of said piercing body being connected to the distal end of said inner tubular body, thereby creating a conduit leading from externally of said outer tubular body through said lumen of said inner tubular body and said lumen of said piercing body to said piercing body sidewall opening, said piercing body being longitudinally moveable in said outer tubular body to an extent permitting the distal end thereof to traverse said aperture and appose said piercing body sidewall opening and said aperture, and passage means laterally adjacent said piercing body permitting flow communication from said aperture to said first passage regardless of the longitudinal location of said piercing body in said distal portion of said outer tubular body.
According to another aspect of the invention, there is provided an apparatus for percutaneously accessing the intrapericardial space, comprising: an elongate outer tubular body having a lumen, a distal portion including a closed distal end, and a passage extending through said body from an aperture in the sidewall of the body adjacent said distal end thereof and including a proximal portion for applying a vacuum, a needle having a sharp leading end, a trailing end and a lumen therethrough from said trailing end to a side opening in the needle adjacent said leading end, said needle being arranged in said tubular body to allow flow communication in said passage from said aperture toward said proximal opening under influence of an applied vacuum and being longitudinally moveable in said passage for said sharp end to traverse said aperture and appose said needle side opening and said aperture without occluding flow communication in said passage, and a filament received in said needle lumen and exiting said tubular body at a proximal portion thereof.
- 6b -According to still another aspect of the invention, there is provided an apparatus for percutaneously accessing the intrapericardial space, comprising: an elongated outer tubular body having a lumen, a closed distal end, an aperture in a sidewall adjacent the closed end, a proximal inlet and a proximal branch for applying a vacuum thereto, a seal in said proximal inlet for sealing said outer tubular body to maintain an applied vacuum in said outer tubular body, a needle carrier arranged and moveable longitudinally in a distal portion of said outer tubular body without occluding flow communication from said aperture toward said branch under influence of an applied vacuum, limiter means in said outer tubular body distally of said branch and proximately of said closure for limiting distal and proximal longitudinal travel of said needle car-rier, a needle having a lumen and carried in said needle carrier, said needle having a sharp leading end extending distally from said carrier and a trailing end extending proximately from said carrier, and having an opening adjacent said sharp leading end alignable with said aperture of said outer tubular body, an inner tubular body having a lumen and received in said outer tubular body lumen without occluding fluid flow therein under influence of an applied vacuum, and connected distally to said trailing end of said needle to provide a conduit including said needle lumen and said inner tubular body lumen, said inner tubular body sealingly exiting said outer tubular body proximately through said seal, and a filament received in said conduit.
According to yet another aspect of the invention, there is provided a use of the apparatus as defined herein, for accessing a pericardial space.
- 6c -According to yet another aspect of the invention, there is provided a use of the apparatus as defined herein, for accessing a pericardial space, wherein the distal end is adapted to be observed fluroscopically.
According to yet another aspect of the invention, there is provided a use of the apparatus as defined herein, for accessing a pericardial space, wherein the lead is adapted to monitor the electrocardial signal of a heart to determine contact of the aperture of said tubular body with a pericardium. body and for drawing a portion of a pericardium away from a heart surface; a piercing element contained in the tubular body adjacent said aperture, wherein said piercing element is for piercing said portion of said pericardium.
The nature, objects, and advantages of the present invention will become more apparent to those skilled in the art when viewed in light of the following detailed description and accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a longitudinal, centerline sectional, side-graphical outline or schematic view of the invention illustrating a preferred embodiment of the pericardiocentesis apparatus for nonsurgical intrapericardial access.
FIG. 2 is a side schematic view of the distal end portion of the invention.
FIG. 3 is a bottom schematic view of the distal end portion of the invention.
- 6d -FIG. 4 is a longitudinal, centerline sectional, side schematic view of the distal end of the invention.
FIG. 5 is a longitudinal, centerline sectional, side schematic view of the distal end of the invention showing the needle in the fully retracted (sheathed) position.
FIG. 6 is cross sectional view of Fig. 5, taken along the line 6-6 of FIG. 5.
FIG. 7 is a longitudinal, centerline sectional, side schematic of the distal end of the invention showing the needle in the fully advanced (extended) position.
FIGS. 8 to 12 are longitudinal, centerline sectional, side schematic view of the distal end of the invention and the pericardium, sequentially illustrating the steps of practicing the present invention to first capture the pericardium, then puncture it with a needle (pericardiocentesis), and then insert a intrapericardial guide wire.
FIG. 8 is a longitudinal, centerline sectional, side schematic view of the distal end of the invention illustrating its position over the anterior surface of the pericardium.
FIG. 9 is a longitudinal, centerline sectional, side schematic view of the distal end of the invention illustrating capture of the pericardium with suction and formation of the pericardial bleb.
FIG. 10 is a longitudinal, centerline sectional, side schematic view of the distal end of the invention illustrating the needle in the fully advanced (extended) position with puncture of the pericardial bleb.
FIG. 11 is a longitudinal, centerline sectional, side schematic view of the distal end of the invention illustrating insertion of the guide wire through the needle into the pericardial space.
FIG. 12 is a side schematic view of the pericardium after removal of the invention illustrating the intrapericardial guide wire.
FIG. 13 is a side schematic view of the distal portion of the invention illustrating an embodiment of the intrapericardial access apparatus with a modified distal head.
FIG. 14 is a front schematic view of the distal portion of the invention illustrating an embodiment of the intrapericardial access apparatus with a modified distal head.
FIG. 15 is a side view of the distal portion of the invention illustrating an embodiment of the intrapericardial access apparatus with an electrode modification.
FIG. 16 is a bottom-view of the distal portion of the invention illustrating an = 25 embodiment of the intrapericardial access apparatus with an electrode modification.
FIG. 17 is an illustration of the heart illustrating the placement of the pericardial access apparatus of the invention inserted subxiphoidally.
SUBSTITUTE SHEET (RULE 26) 14 Olr !T997 Detailed Description Of The Preferred Embodiments Referring to FIG. 1, an introducer apparatus 100 for percutaneously accessing the intrapericardial space and constructed in accordance with this invention, comprises a distal end portion 102 which is attached to and may be considered a distal extension of first elongate outer tubular body 104 which in turn is attached to a connector portion 106, which may be considered a proximal extension of tubular body 104. Connector portion 106 has a side branch 108 which in turn is connected to a vacuum supply 116. A second or inner elongate tubular body 112 having a proximal end 111 and a distal end 113 extends into first or outer tubular body 104 including connector portion 106 from outside outer tubular body 104, creating a passage 120 between first and inner tubular bodies 104 and 112. Passage 120 is an annulus where first and inner tubular bodies 104 and 112 are circular in cross section. At the end of ~"- connector 106 is a seal or gasket 110 which seals passage 120 inside of the tubular body 104 and connector portion 106 from ambient pressure while still permitting inner tubular body 112 to move in and out of connector portion 106. Loaded within tubular body 112 is a guide wire 114.
The distal end portion 102 is illustrated in FIG. 2 with a close-up side-view.
The bottom-view of FIG. 2 is illustrated in FIG. 3. A centerline sectional side-view of FIG. 2 is illustrated in FIG 4. The distal end portion 102 of introducer apparatus 100 is radio-opaque, rigid, and contains an axial passage 120 which is part of a continuous passage 120 in segments 106 and 108 of outer body 104. The passage 120 in distal portion 102 terminates axially at a closure or end portion 121. A radial bore 122 in tubular body sidewall 119 adjacent closure end 121 intersects, suitably orthogonally, passage 120 and creates a cavity at 122 entered by aperture 123. A needle carrier block 126 is arranged and moveable longitudinally in passage 120 without occluding flow communication of fluid from aperture 123 toward branch 108 under influence of vacuum source 116. A needle 124 having an axial lumen 125 is carried in needle carrier 126 and attached to the needle carrier using a set screw 128.
Needle 124 has a sharp leading or distal end 127 extending distally from carrier 126 and a trailing or proximal end 129 extending proximately from carrier 126. Needle 124 includes a sidewall lateral opening 131 adjacent sharp leading end 127 and positioned to be apposed to or alignedly juxtaposed over aperture 123 of radial bore 122 in passage 120 when needle carrier 126 is advanced in tubular body distal portion 102. At sidewall opening 131, lumen 125 accesses cavity 122 where piercing of pericardium 144 occurs. Distal end 113 of the second or inner tubular body 112 is axially connected to the trailing end 129 of needle 124, as shown in FIG. 2.
AMENDED SHEET
FIG. 8 is a longitudinal, centerline sectional, side schematic view of the distal end of the invention illustrating its position over the anterior surface of the pericardium.
FIG. 9 is a longitudinal, centerline sectional, side schematic view of the distal end of the invention illustrating capture of the pericardium with suction and formation of the pericardial bleb.
FIG. 10 is a longitudinal, centerline sectional, side schematic view of the distal end of the invention illustrating the needle in the fully advanced (extended) position with puncture of the pericardial bleb.
FIG. 11 is a longitudinal, centerline sectional, side schematic view of the distal end of the invention illustrating insertion of the guide wire through the needle into the pericardial space.
FIG. 12 is a side schematic view of the pericardium after removal of the invention illustrating the intrapericardial guide wire.
FIG. 13 is a side schematic view of the distal portion of the invention illustrating an embodiment of the intrapericardial access apparatus with a modified distal head.
FIG. 14 is a front schematic view of the distal portion of the invention illustrating an embodiment of the intrapericardial access apparatus with a modified distal head.
FIG. 15 is a side view of the distal portion of the invention illustrating an embodiment of the intrapericardial access apparatus with an electrode modification.
FIG. 16 is a bottom-view of the distal portion of the invention illustrating an = 25 embodiment of the intrapericardial access apparatus with an electrode modification.
FIG. 17 is an illustration of the heart illustrating the placement of the pericardial access apparatus of the invention inserted subxiphoidally.
SUBSTITUTE SHEET (RULE 26) 14 Olr !T997 Detailed Description Of The Preferred Embodiments Referring to FIG. 1, an introducer apparatus 100 for percutaneously accessing the intrapericardial space and constructed in accordance with this invention, comprises a distal end portion 102 which is attached to and may be considered a distal extension of first elongate outer tubular body 104 which in turn is attached to a connector portion 106, which may be considered a proximal extension of tubular body 104. Connector portion 106 has a side branch 108 which in turn is connected to a vacuum supply 116. A second or inner elongate tubular body 112 having a proximal end 111 and a distal end 113 extends into first or outer tubular body 104 including connector portion 106 from outside outer tubular body 104, creating a passage 120 between first and inner tubular bodies 104 and 112. Passage 120 is an annulus where first and inner tubular bodies 104 and 112 are circular in cross section. At the end of ~"- connector 106 is a seal or gasket 110 which seals passage 120 inside of the tubular body 104 and connector portion 106 from ambient pressure while still permitting inner tubular body 112 to move in and out of connector portion 106. Loaded within tubular body 112 is a guide wire 114.
The distal end portion 102 is illustrated in FIG. 2 with a close-up side-view.
The bottom-view of FIG. 2 is illustrated in FIG. 3. A centerline sectional side-view of FIG. 2 is illustrated in FIG 4. The distal end portion 102 of introducer apparatus 100 is radio-opaque, rigid, and contains an axial passage 120 which is part of a continuous passage 120 in segments 106 and 108 of outer body 104. The passage 120 in distal portion 102 terminates axially at a closure or end portion 121. A radial bore 122 in tubular body sidewall 119 adjacent closure end 121 intersects, suitably orthogonally, passage 120 and creates a cavity at 122 entered by aperture 123. A needle carrier block 126 is arranged and moveable longitudinally in passage 120 without occluding flow communication of fluid from aperture 123 toward branch 108 under influence of vacuum source 116. A needle 124 having an axial lumen 125 is carried in needle carrier 126 and attached to the needle carrier using a set screw 128.
Needle 124 has a sharp leading or distal end 127 extending distally from carrier 126 and a trailing or proximal end 129 extending proximately from carrier 126. Needle 124 includes a sidewall lateral opening 131 adjacent sharp leading end 127 and positioned to be apposed to or alignedly juxtaposed over aperture 123 of radial bore 122 in passage 120 when needle carrier 126 is advanced in tubular body distal portion 102. At sidewall opening 131, lumen 125 accesses cavity 122 where piercing of pericardium 144 occurs. Distal end 113 of the second or inner tubular body 112 is axially connected to the trailing end 129 of needle 124, as shown in FIG. 2.
AMENDED SHEET
This connection creates a conduit leading from externaIly of outer tubular body 104 through inner tubular body 112 and axial lumen 125 to needle sidewall opening 131.
This enables access to the pericardial space through sidewall opening 131 after pericardium 144 is pierced.
In FIGS 1-11 this conduit is occupied by guidewire 114. The purpose of lumen 125 and the conduit leading through inner tube 112 is not to supply a vacuum to withdraw fluid. That is the purpose of passage 120, and passage 120 is much larger in cross section than lumen 125.
Suitably the ratio of cross sectional areas of passage 120 to lumen 125 exceeds about 5 and may be up to about 200, more preferably from about 5 to about 100, the larger the number, the greater the vacuum force available. However, the vacuum force applied need be only sufficient to acquire and draw a bleb of pericardium into cavity 122 for piercing so that whatever is to be introduced through needle 124 can be delivered into the pericardial space so accessed.
FIG. 5 is identical to FIG. 4 except that the needle carrier 126 and retaining screw 132 are not sectioned. Needle carrier 126, aside from providing a mechanism to mount needle 124 in proper alignment to a platform, also moves between two travel limiters arranged in tubular body distal portion 102 proximately of aperture 123 for limiting longitudinal movement of needle carrier 126 and hence needle 124 in tubular body distal portion 102 toward and away from closed distal end 121. Carrier 126 includes along an outer surface a longitudinal recess or groove 134 having a blind distal end 138 and an open proximal end 139. An interior protrusion such as a set screw 132 is mounted on tubular body 102 and extends transversely radially inward, as illustrated in FIG. 6, to protrude into groove 134. At the fully retracted or proximal position of needle holder 126, set screw 132 contacts the blind end 138 of groove 134. Another limiter comprises a constriction 140 at stop 136 in tubular body distal portion 102 distal to and narrower than needle carrier 126 that prevents further distal movement of needle holder 126 past the proximal portion of constriction 140 at stop 136, as shown in FIG. 7, fixing the fully extended or distal position of needle holder 126 in tubular body 102. As illustrated in FIGS. 5 and 7 the tip of needle 124 in the fully retracted position (FIG. 5) is limited by protrusion 132 and does not violate the boundary of bore 122. In the fully extended position (FIG. 7) limited by constriction 140 at stop 136, needle 124 extends significantly into bore 122.
Instead of this arrangement to control travel, both ends of groove 134 can be blind, with travel being limited by the stop; or a constriction can be furnished both distally and = proximally of carrier 126. Indeed, the travel limiter for the fully extended position of needle 124 and needle carrier 126 suitably is provided by end closure 121 of distal portion 102 of SUBSTiTUTE SHEET (RULE 26) outer tube 104. However, the embodiment illustrated is of simple construction and is satisfactory.
FIG. 6 is section 6-6 of FIG. 5. As seen in Fig. 6, needle carrier 126 is relieved in an upper of its body, providing a passage 130 laterally adjacent carrier 126 permitting flow communication from aperture 123 to the portion of passage 120 proximal of carrier 126, regardless of the longitudinal location of needle carrier 126 in the distal portion of outer tubular body 102. Subambient pressure provided by vacuum source 116 results in ambient gas flow from aperture 123 of the tubular body distal portion 102, through passage 120, around needle carrier 126 at passage 130, inside the annulus portion of passage 120 to side branch 108, to the vacuum source 116. Instead of relief of the outside periphery of carrier 126, other means of passage of fluid flow past carrier 126 may be employed, including longitudinal grooves along the periphery of carrier body 126 or separate channels external to the inner periphery of tubular body 104 accessed through openings into the passage 120 located beyond the limit of travel of carrier 126.
Second or inner tubular body 112, containing the guide wire 114, is sealed from subambient pressure via seal 110 on connector 106.
FIGS. 8 to 10 more particularly illustrate sequentially the inventive method for puncture of the pericardial wall. At the start of the procedure, a small subxiphoid incision is made in the skin. The method of the present invention for pericardiocentesis is then carried out through the following steps.
The tubular body device 104, with radio-opaque distal end 121, is inserted through the subxiphoid incision and advanced percutaneously, with the aid of fluoroscopy, over the diaphragm into the mediastinal space and is positioned so that the aperture 123 on the tubular body distal end 102 is over the anterior surface of the pericardial sac 144 (FIG. 8). Also shown in section is the wall of the ventricle 146 and the intrapericardial space 148.
Vacuum supply 116, connected to the branch portion 108 of outer tubular body 104, is then energized and air is evacuated from the distal portion 102 of tubular body 104 and the side opening 122 which is in contact with the pericardium 144. Once captured by suction, the pericardial sac 144 stretches to form a"bleb" 150 through aperture 123 into side opening 122 (FIG. 9).
SUBSTITUTE SHEET (RULE 26) After pericardial bleb 150 forms, as shown in FIG. 10, the operator may then advance needle 124, which is sheathed inside distal end 102 of outer tubular body 104 and aligned by movable needle holder 126. This is done by advancing inner tubular body 112 (FIG. 1) until needle holder 126 encounters stop 136. This forward movement causes needle 124 to sequentially prick and then puncture the pericardial bleb 150. The bleb 150 is pierced by needle 124 without contact or injury to the heart 146 since bleb 150 and needle 124 are isolated within cavity 122.
At this point the needle can be withdrawn to leave a hole in the pericardium for access in any of the ways generally described above. Figs. 11-12 illustrate the aspect of the invention in which a guidewire is introduced into the pericardial space through the hole that was created in the pericardium.
After the hole is created in the pericardium, and with needle 124 in the fully advanced position at stop 136, the vacuum system is deactivated and a flexible guide wire 114 preloaded in needle 124 is then pushed through needle 124 into the pericardial space 148 between the heart 146 and pericardium 144 (FIG. 11). The needle is then retracted and the apparatus 100 is percutaneously removed from the patient leaving guide wire 114 in intrapericardial space 148 as illustrated in FIG. 12. Guide wire 114 facilitates access to the interior of the pericardium.
Referring now to FIG. 17, there is illustrated a human heart 200 and ventricle showing the epicardial coronary arteries 202, the pericardial sac 144 enveloping heart 200, and pericardial space 148 containing pericardial fluid 206 bathing (exaggerated for purposes of illustration) heart 200 within pericardial sac 144. One of the coronary arteries 202 is indicated to be stenosed at 203. Below heart 200 is the diaphragm musculature 208. In the chest of the patient in front of heart 200 is the sternum 210 and the lower extension thereof called the xiphoid process 211. Shown percutaneously inserted below xiphoid process 211 is introducer 100 of this invention which has been advanced to a position over pericardium 144 with stabilizer portion 160 maintaining distal potion 102 of outer tube 104 substantially parallel to pericardium 204, assuring that aperture 123 and radial cavity 122 (not visible, but see FIGS. 8-11) are substantially normal to the pericardium for lifting a portion or bleb 150 of pericardium 144 into cavity 123 for needle piercing and hole creation substantially parallel to the heart to avoid risk of puncture of the heart. In FIG. 17, guidewire 114 has been advanced through the hole created in the pericardium.
SUBSTITUTE SHEET (RULE 26) After guidewire 114 has been advanced into the pericardial space, a catheter may then be percutaneously advanced over guide wire 114 into the pericardial space for the withdrawal of fluid, and/or the intrapericardial injection or infusion of therapeutic agents, or the intrapericardial insertion of implantable materials.
As mentioned before, the invention involves only in part the ability to introduce a guidewire and thereby a catheter into the pericardial space. The facility of the conduit provided by lumen 125 in flow communication with the lumen of inner tubular body 112 exiting outside outer tubular body 104 at its proximal end 111 at segment 106 gives a channel for fluids, pastes, gels, particles and solids passage directly to the pericardial space for administration of fluid or implant therapeutic agents to the heart or for implantation of electro-or photoconductive cardioregulatory apparatus, suitably filamentary devices such as defibrillator electrodes, which, after withdrawal of apparatus 100, can be accessed outside the patients body and connected to body exterior devices for regulation or monitoring of the heart.Apparatus 100 may be supplied for use with this device channel empty, and when access is gained to pericardial space 146 as has been described, the agents to be delivered to the pericardial space can be pumped, injected or infused directly through this access channel to exit needle side opening 131 (still within pericardial space 146) and enter the pericardial space.
Alternatively, apparatus 100 can be furnished preloaded with a filament in needle 125 which can be advanced into the pericardial space after it is accessed with apparatus 100. The - 12a -filament may itself be hollow and serve as a catheter for in-dwelling administration of therapeutic agents after removal of apparatus 100. The filament can be solid, as in the instance of a guidewire or electro- or photo-conductive cardioregulation lead.
The present application is assigned to the assignee of United States Patent Number 5,681,278 filed June 23, 1994, which describes a method of treating the coronary arteries of the heart that comprises application of therapeutic substances to the exterior surface of the heart. As already mentioned, fluid injected into the pericardial space accumulates in the atrioventricular and interventricular grooves.
Since the epicardial coronary arteries are located in the grooves of the heart, a bioactive therapeutic substance delivered into the pericardial space through the methodology and device of this invention can accumulate and be concentrated over the coronary blood vessels.
Intrapericardial drug delivery applications include injection/infusion of liquid drug preparations via a catheter placed according to this invention ("free drugs"), and delivery of constrained release materials for controlled drug release and time-based (long term) pharmacologic therapy, using the method and apparatus of this invention. Such constrained release materials suitably include implants and may comprise biopolymers, biodegradable fibers, liposomes, biodegradable polymeric microspheres, pastes, and gels.Thus this invention provides methods and means for accessing the pericardial space and delivery of a biodegradable drug loaded fiber which releases drug into the pericardial fluid for extended periods of time, for delivery of drug loaded liposomes or drug release microspheres (biodegradable polymer) to accumulate in the ventricular grooves and provide localized drug delivery to the coronary arteries, and for delivery of a drug loaded fibrin biopolymer or drug release gel which can be squeezed into the ventricular sulcus sites providing coronary artery site specific drug delivery. Depending on the viscosity of the substances used, regional site-specific treatment to a particular portion of the coronary circulation can be achieved by injecting the drug delivery material into the pericardium at a particular location using the apparatus of this invention.
Cardiovascular drugs for intrapericardial delivery can include vasodilator, antiplatelet, anticoagulant, thrombolytic, anti-inflammatory,antiarrhythm ic, inotropic, antimitotic, angiogenic, antiatherogenic and gene therapy agents. Reference is made to co-pending U.S. Patent No. 5,681,278 filed June 23, 1994 for a description of the methodology of treatment of cardiovascular disease by drugs placed in the pericardial space.
FIG. 13 illustrates an embodiment of the present invention in which distal end 121 of the outer tubular body 104 -13a -comprises a stabilizer portion 160. FIG. 14 is a front view of FIG.13. Stabilizer portion 160 is axially fixed to distal portion 102 of body 104, and is frontally ramped in a gently upward slope as indicated by 164, and narrows vertically from bottom to top as seen in FIG. 14. This frontal sloping eases entry under the sternum during insertion of the tubular body 104. Longitudinal grooves 162 along the upper surface of nose 160 help strip or otherwise remove fatty tissue on the pericardial surface away from the device, as well as provide a means of orienting the apparatus 100 to the surface of the pericardium. FIG. 14 indicates two downwardly shaped longitudinal nodes 166 which create a longitudinal concavity 168 between them. This concavity keeps the pericardium from bunching as the device is moved over it.
FIG. 15 illustrates an embodiment of the present invention which includes an electroconductive terminal adjacent aperture 123 of outer tubular body distal portion 102 and a terminal lead electroconductively communicating exteriorly outer tubular body remote from distal portion 102. FIG. 16 is a bottom view of FIG. 15. A ring 170, which is electrically conductive around side opening entrance 123, communicates to an electrically conductive strip 172 which is a part of tubular body 102. FIG. 15 indicates part of the tubular body 104, cut away to show the addition of a wire 174 or equivalent which is attached to the electrically conductive material 172. The purpose of this device enhancement is to measure the electrocardiogram (EKG) signal from the heart 146 and pericardium 144, and transmit this signal back to the proximal end of the invention 100 where it is coupled to a EKG display monitor. Coupling of the invention 100 to a EKG monitor adds further information that the device is contacting the pericardium 144. Thus this invention further comprising monitoring the electrocardial signal of the heart to determine contact of aperture 123 of tubular body with the pericardium during said percutaneous insertion step.
The vacuum in tubular body 104 may also be monitored to detecta decrease in vacuum pressure marking capture of a bleb portion 150 of pericardium in aperture 123 and lateral opening 122.
From the foregoing detailed description, it is believed apparent that the present invention provides a method and apparatus for accessing the pericardial space by needle puncture (pericardiocentesis) without the need for invasive surgery and with a reduced risk of injury to the heart. It should be understood that the invention is not intended to be limited to the specifics of the described preferred embodiments, but is defined by the accompanying claims.
SUBSTITUTE SHEET (RULE 26)
This enables access to the pericardial space through sidewall opening 131 after pericardium 144 is pierced.
In FIGS 1-11 this conduit is occupied by guidewire 114. The purpose of lumen 125 and the conduit leading through inner tube 112 is not to supply a vacuum to withdraw fluid. That is the purpose of passage 120, and passage 120 is much larger in cross section than lumen 125.
Suitably the ratio of cross sectional areas of passage 120 to lumen 125 exceeds about 5 and may be up to about 200, more preferably from about 5 to about 100, the larger the number, the greater the vacuum force available. However, the vacuum force applied need be only sufficient to acquire and draw a bleb of pericardium into cavity 122 for piercing so that whatever is to be introduced through needle 124 can be delivered into the pericardial space so accessed.
FIG. 5 is identical to FIG. 4 except that the needle carrier 126 and retaining screw 132 are not sectioned. Needle carrier 126, aside from providing a mechanism to mount needle 124 in proper alignment to a platform, also moves between two travel limiters arranged in tubular body distal portion 102 proximately of aperture 123 for limiting longitudinal movement of needle carrier 126 and hence needle 124 in tubular body distal portion 102 toward and away from closed distal end 121. Carrier 126 includes along an outer surface a longitudinal recess or groove 134 having a blind distal end 138 and an open proximal end 139. An interior protrusion such as a set screw 132 is mounted on tubular body 102 and extends transversely radially inward, as illustrated in FIG. 6, to protrude into groove 134. At the fully retracted or proximal position of needle holder 126, set screw 132 contacts the blind end 138 of groove 134. Another limiter comprises a constriction 140 at stop 136 in tubular body distal portion 102 distal to and narrower than needle carrier 126 that prevents further distal movement of needle holder 126 past the proximal portion of constriction 140 at stop 136, as shown in FIG. 7, fixing the fully extended or distal position of needle holder 126 in tubular body 102. As illustrated in FIGS. 5 and 7 the tip of needle 124 in the fully retracted position (FIG. 5) is limited by protrusion 132 and does not violate the boundary of bore 122. In the fully extended position (FIG. 7) limited by constriction 140 at stop 136, needle 124 extends significantly into bore 122.
Instead of this arrangement to control travel, both ends of groove 134 can be blind, with travel being limited by the stop; or a constriction can be furnished both distally and = proximally of carrier 126. Indeed, the travel limiter for the fully extended position of needle 124 and needle carrier 126 suitably is provided by end closure 121 of distal portion 102 of SUBSTiTUTE SHEET (RULE 26) outer tube 104. However, the embodiment illustrated is of simple construction and is satisfactory.
FIG. 6 is section 6-6 of FIG. 5. As seen in Fig. 6, needle carrier 126 is relieved in an upper of its body, providing a passage 130 laterally adjacent carrier 126 permitting flow communication from aperture 123 to the portion of passage 120 proximal of carrier 126, regardless of the longitudinal location of needle carrier 126 in the distal portion of outer tubular body 102. Subambient pressure provided by vacuum source 116 results in ambient gas flow from aperture 123 of the tubular body distal portion 102, through passage 120, around needle carrier 126 at passage 130, inside the annulus portion of passage 120 to side branch 108, to the vacuum source 116. Instead of relief of the outside periphery of carrier 126, other means of passage of fluid flow past carrier 126 may be employed, including longitudinal grooves along the periphery of carrier body 126 or separate channels external to the inner periphery of tubular body 104 accessed through openings into the passage 120 located beyond the limit of travel of carrier 126.
Second or inner tubular body 112, containing the guide wire 114, is sealed from subambient pressure via seal 110 on connector 106.
FIGS. 8 to 10 more particularly illustrate sequentially the inventive method for puncture of the pericardial wall. At the start of the procedure, a small subxiphoid incision is made in the skin. The method of the present invention for pericardiocentesis is then carried out through the following steps.
The tubular body device 104, with radio-opaque distal end 121, is inserted through the subxiphoid incision and advanced percutaneously, with the aid of fluoroscopy, over the diaphragm into the mediastinal space and is positioned so that the aperture 123 on the tubular body distal end 102 is over the anterior surface of the pericardial sac 144 (FIG. 8). Also shown in section is the wall of the ventricle 146 and the intrapericardial space 148.
Vacuum supply 116, connected to the branch portion 108 of outer tubular body 104, is then energized and air is evacuated from the distal portion 102 of tubular body 104 and the side opening 122 which is in contact with the pericardium 144. Once captured by suction, the pericardial sac 144 stretches to form a"bleb" 150 through aperture 123 into side opening 122 (FIG. 9).
SUBSTITUTE SHEET (RULE 26) After pericardial bleb 150 forms, as shown in FIG. 10, the operator may then advance needle 124, which is sheathed inside distal end 102 of outer tubular body 104 and aligned by movable needle holder 126. This is done by advancing inner tubular body 112 (FIG. 1) until needle holder 126 encounters stop 136. This forward movement causes needle 124 to sequentially prick and then puncture the pericardial bleb 150. The bleb 150 is pierced by needle 124 without contact or injury to the heart 146 since bleb 150 and needle 124 are isolated within cavity 122.
At this point the needle can be withdrawn to leave a hole in the pericardium for access in any of the ways generally described above. Figs. 11-12 illustrate the aspect of the invention in which a guidewire is introduced into the pericardial space through the hole that was created in the pericardium.
After the hole is created in the pericardium, and with needle 124 in the fully advanced position at stop 136, the vacuum system is deactivated and a flexible guide wire 114 preloaded in needle 124 is then pushed through needle 124 into the pericardial space 148 between the heart 146 and pericardium 144 (FIG. 11). The needle is then retracted and the apparatus 100 is percutaneously removed from the patient leaving guide wire 114 in intrapericardial space 148 as illustrated in FIG. 12. Guide wire 114 facilitates access to the interior of the pericardium.
Referring now to FIG. 17, there is illustrated a human heart 200 and ventricle showing the epicardial coronary arteries 202, the pericardial sac 144 enveloping heart 200, and pericardial space 148 containing pericardial fluid 206 bathing (exaggerated for purposes of illustration) heart 200 within pericardial sac 144. One of the coronary arteries 202 is indicated to be stenosed at 203. Below heart 200 is the diaphragm musculature 208. In the chest of the patient in front of heart 200 is the sternum 210 and the lower extension thereof called the xiphoid process 211. Shown percutaneously inserted below xiphoid process 211 is introducer 100 of this invention which has been advanced to a position over pericardium 144 with stabilizer portion 160 maintaining distal potion 102 of outer tube 104 substantially parallel to pericardium 204, assuring that aperture 123 and radial cavity 122 (not visible, but see FIGS. 8-11) are substantially normal to the pericardium for lifting a portion or bleb 150 of pericardium 144 into cavity 123 for needle piercing and hole creation substantially parallel to the heart to avoid risk of puncture of the heart. In FIG. 17, guidewire 114 has been advanced through the hole created in the pericardium.
SUBSTITUTE SHEET (RULE 26) After guidewire 114 has been advanced into the pericardial space, a catheter may then be percutaneously advanced over guide wire 114 into the pericardial space for the withdrawal of fluid, and/or the intrapericardial injection or infusion of therapeutic agents, or the intrapericardial insertion of implantable materials.
As mentioned before, the invention involves only in part the ability to introduce a guidewire and thereby a catheter into the pericardial space. The facility of the conduit provided by lumen 125 in flow communication with the lumen of inner tubular body 112 exiting outside outer tubular body 104 at its proximal end 111 at segment 106 gives a channel for fluids, pastes, gels, particles and solids passage directly to the pericardial space for administration of fluid or implant therapeutic agents to the heart or for implantation of electro-or photoconductive cardioregulatory apparatus, suitably filamentary devices such as defibrillator electrodes, which, after withdrawal of apparatus 100, can be accessed outside the patients body and connected to body exterior devices for regulation or monitoring of the heart.Apparatus 100 may be supplied for use with this device channel empty, and when access is gained to pericardial space 146 as has been described, the agents to be delivered to the pericardial space can be pumped, injected or infused directly through this access channel to exit needle side opening 131 (still within pericardial space 146) and enter the pericardial space.
Alternatively, apparatus 100 can be furnished preloaded with a filament in needle 125 which can be advanced into the pericardial space after it is accessed with apparatus 100. The - 12a -filament may itself be hollow and serve as a catheter for in-dwelling administration of therapeutic agents after removal of apparatus 100. The filament can be solid, as in the instance of a guidewire or electro- or photo-conductive cardioregulation lead.
The present application is assigned to the assignee of United States Patent Number 5,681,278 filed June 23, 1994, which describes a method of treating the coronary arteries of the heart that comprises application of therapeutic substances to the exterior surface of the heart. As already mentioned, fluid injected into the pericardial space accumulates in the atrioventricular and interventricular grooves.
Since the epicardial coronary arteries are located in the grooves of the heart, a bioactive therapeutic substance delivered into the pericardial space through the methodology and device of this invention can accumulate and be concentrated over the coronary blood vessels.
Intrapericardial drug delivery applications include injection/infusion of liquid drug preparations via a catheter placed according to this invention ("free drugs"), and delivery of constrained release materials for controlled drug release and time-based (long term) pharmacologic therapy, using the method and apparatus of this invention. Such constrained release materials suitably include implants and may comprise biopolymers, biodegradable fibers, liposomes, biodegradable polymeric microspheres, pastes, and gels.Thus this invention provides methods and means for accessing the pericardial space and delivery of a biodegradable drug loaded fiber which releases drug into the pericardial fluid for extended periods of time, for delivery of drug loaded liposomes or drug release microspheres (biodegradable polymer) to accumulate in the ventricular grooves and provide localized drug delivery to the coronary arteries, and for delivery of a drug loaded fibrin biopolymer or drug release gel which can be squeezed into the ventricular sulcus sites providing coronary artery site specific drug delivery. Depending on the viscosity of the substances used, regional site-specific treatment to a particular portion of the coronary circulation can be achieved by injecting the drug delivery material into the pericardium at a particular location using the apparatus of this invention.
Cardiovascular drugs for intrapericardial delivery can include vasodilator, antiplatelet, anticoagulant, thrombolytic, anti-inflammatory,antiarrhythm ic, inotropic, antimitotic, angiogenic, antiatherogenic and gene therapy agents. Reference is made to co-pending U.S. Patent No. 5,681,278 filed June 23, 1994 for a description of the methodology of treatment of cardiovascular disease by drugs placed in the pericardial space.
FIG. 13 illustrates an embodiment of the present invention in which distal end 121 of the outer tubular body 104 -13a -comprises a stabilizer portion 160. FIG. 14 is a front view of FIG.13. Stabilizer portion 160 is axially fixed to distal portion 102 of body 104, and is frontally ramped in a gently upward slope as indicated by 164, and narrows vertically from bottom to top as seen in FIG. 14. This frontal sloping eases entry under the sternum during insertion of the tubular body 104. Longitudinal grooves 162 along the upper surface of nose 160 help strip or otherwise remove fatty tissue on the pericardial surface away from the device, as well as provide a means of orienting the apparatus 100 to the surface of the pericardium. FIG. 14 indicates two downwardly shaped longitudinal nodes 166 which create a longitudinal concavity 168 between them. This concavity keeps the pericardium from bunching as the device is moved over it.
FIG. 15 illustrates an embodiment of the present invention which includes an electroconductive terminal adjacent aperture 123 of outer tubular body distal portion 102 and a terminal lead electroconductively communicating exteriorly outer tubular body remote from distal portion 102. FIG. 16 is a bottom view of FIG. 15. A ring 170, which is electrically conductive around side opening entrance 123, communicates to an electrically conductive strip 172 which is a part of tubular body 102. FIG. 15 indicates part of the tubular body 104, cut away to show the addition of a wire 174 or equivalent which is attached to the electrically conductive material 172. The purpose of this device enhancement is to measure the electrocardiogram (EKG) signal from the heart 146 and pericardium 144, and transmit this signal back to the proximal end of the invention 100 where it is coupled to a EKG display monitor. Coupling of the invention 100 to a EKG monitor adds further information that the device is contacting the pericardium 144. Thus this invention further comprising monitoring the electrocardial signal of the heart to determine contact of aperture 123 of tubular body with the pericardium during said percutaneous insertion step.
The vacuum in tubular body 104 may also be monitored to detecta decrease in vacuum pressure marking capture of a bleb portion 150 of pericardium in aperture 123 and lateral opening 122.
From the foregoing detailed description, it is believed apparent that the present invention provides a method and apparatus for accessing the pericardial space by needle puncture (pericardiocentesis) without the need for invasive surgery and with a reduced risk of injury to the heart. It should be understood that the invention is not intended to be limited to the specifics of the described preferred embodiments, but is defined by the accompanying claims.
SUBSTITUTE SHEET (RULE 26)
Claims (48)
1. An apparatus for percutaneously accessing the intrapericardial space, comprising :
an outer elongated tubular body having a lumen, a distal portion including a closed distal end, an aperture in a sidewall adjacent the closed end, and a proximal portion for applying a vacuum thereto, an inner elongated tubular body having a lumen and a distal end sealingly extending into said outer tubular body lumen from a proximal end external to said outer tubular body, creating a first passage between said outer and inner tubular bodies, a piercing body disposed in said distal portion of said outer tubular body adjacent said aperture, said piercing body having a sharp distal end and a lumen extending therethrough from a proximal end thereof to a sidewall opening therein adjacent such sharp distal end, the proximal end of said piercing body being connected to the distal end of said inner tubular body, thereby creating a conduit leading from externally of said outer tubular body through said lumen of said inner tubular body and said lumen of said piercing body to said piercing body sidewall opening, said piercing body being longitudinally moveable in said outer tubular body to an extent permitting the distal end thereof to traverse said aperture and appose said piercing body sidewall opening and said aperture, and passage means laterally adjacent said piercing body permitting flow communication from said aperture to said first passage regardless of the longitudinal location of said piercing body in said distal portion of said outer tubular body.
an outer elongated tubular body having a lumen, a distal portion including a closed distal end, an aperture in a sidewall adjacent the closed end, and a proximal portion for applying a vacuum thereto, an inner elongated tubular body having a lumen and a distal end sealingly extending into said outer tubular body lumen from a proximal end external to said outer tubular body, creating a first passage between said outer and inner tubular bodies, a piercing body disposed in said distal portion of said outer tubular body adjacent said aperture, said piercing body having a sharp distal end and a lumen extending therethrough from a proximal end thereof to a sidewall opening therein adjacent such sharp distal end, the proximal end of said piercing body being connected to the distal end of said inner tubular body, thereby creating a conduit leading from externally of said outer tubular body through said lumen of said inner tubular body and said lumen of said piercing body to said piercing body sidewall opening, said piercing body being longitudinally moveable in said outer tubular body to an extent permitting the distal end thereof to traverse said aperture and appose said piercing body sidewall opening and said aperture, and passage means laterally adjacent said piercing body permitting flow communication from said aperture to said first passage regardless of the longitudinal location of said piercing body in said distal portion of said outer tubular body.
2. The apparatus of claim 1 further comprising limiter means arranged in said distal portion of outer tubular body proximately of said aperture for limiting longitudinal movement of said piercing body in said outer tubular body toward and away from said closed distal end of the outer tubular body.
3. The apparatus of claim 1 in which at least said distal end of said outer tubular body is radio-opaque.
4. The apparatus of claim 1 further comprising an electroconductive terminal adjacent said aperture and a terminal lead electroconductively communicating said terminal exteriorly of outer tubular body remotely from said distal end of said outer tubular body.
5. The apparatus of claim 1 in which said distal portion of said outer tubular body is axially fixed and wherein said distal end thereof further comprises a stabilizer portion for preventing axial rotation of said distal portion.
6. The apparatus of claim 5 in which said stabilizer portion has a width to height aspect exceeding unity.
7. The apparatus of claim 6 wherein said stabilizer portion comprises a frontally ramped nose having an upper side and an underside.
8. The apparatus of claim 7 wherein said stabilizer portion underside includes a longitudinal concavity.
9. The apparatus of claim 7 wherein said stabilizer portion includes longitudinal grooves along the upper side thereof.
10. The apparatus of claim 1 further comprising a filament extending into said conduit from exteriorly of said outer tubular body.
11. An apparatus for percutaneously accessing the intrapericardial space, comprising:
an elongate outer tubular body having a lumen, a distal portion including a closed distal end, and a passage extending through said body from an aperture in the sidewall of the body adjacent said distal end thereof and including a proximal portion for applying a vacuum, a needle having a sharp leading end, a trailing end and a lumen therethrough from said trailing end to a side opening in the needle adjacent said leading end, said needle being arranged in said tubular body to allow flow communication in said passage from said aperture toward said proximal opening under influence of an applied vacuum and being longitudinally moveable in said passage for said sharp end to traverse said aperture and appose said needle side opening and said aperture without occluding flow communication in said passage, and a filament received in said needle lumen and exiting said tubular body at a proximal portion thereof.
an elongate outer tubular body having a lumen, a distal portion including a closed distal end, and a passage extending through said body from an aperture in the sidewall of the body adjacent said distal end thereof and including a proximal portion for applying a vacuum, a needle having a sharp leading end, a trailing end and a lumen therethrough from said trailing end to a side opening in the needle adjacent said leading end, said needle being arranged in said tubular body to allow flow communication in said passage from said aperture toward said proximal opening under influence of an applied vacuum and being longitudinally moveable in said passage for said sharp end to traverse said aperture and appose said needle side opening and said aperture without occluding flow communication in said passage, and a filament received in said needle lumen and exiting said tubular body at a proximal portion thereof.
12. The apparatus of claim 11 further comprising a inner tubular body received in said outer tubular body lumen without occluding flow communication in said passage, said inner tubular body having a lumen receiving said filament and being connected distally to said trailing end of said needle and sealingly exiting said outer tubular body at a proximal portion of said outer tubular body.
13. The apparatus of claim 11 further comprising limiter means arranged in said distal portion of said outer tubular body distally of said proximal opening and proximately of said distal aperture for limiting longitudinal movement of said needle in said passage toward and away from said closed distal end.
14. The apparatus of claim 11 wherein said distal end of said outer tubular body distal portion comprises a frontally ramped stabilizer portion having a width to height aspect exceeding unity.
15. The apparatus of claim 14 wherein said stabilizer portion has an underside including a longitudinal concavity.
16. The apparatus of claim 15 wherein said stabilizer portion includes longitudinal grooves along the upper side thereof.
17. The apparatus of claim 11 in which at least said distal end is radio-opaque.
18. The apparatus of claim 11 further comprising an electroconductive terminal adjacent said aperture of said outer tubular body and a terminal lead electroconductively communicating exteriorly of said tubular body remote from said distal end thereof.
19. An apparatus for percutaneously accessing the intrapericardial space, comprising:
an elongated outer tubular body having a lumen, a closed distal end, an aperture in a sidewall adjacent the closed end, a proximal inlet and a proximal branch for applying a vacuum thereto, a seal in said proximal inlet for sealing said outer tubular body to maintain an applied vacuum in said outer tubular body, a needle carrier arranged and moveable longitudinally in a distal portion of said outer tubular body without occluding flow communication from said aperture toward said branch under influence of an applied vacuum, limiter means in said outer tubular body distally of said branch and proximately of said closure for limiting distal and proximal longitudinal travel of said needle carrier, a needle having a lumen and carried in said needle carrier, said needle having a sharp leading end extending distally from said carrier and a trailing end extending proximately from said carrier, and having an opening adjacent said sharp leading end alignable with said aperture of said outer tubular body, an inner tubular body having a lumen and received in said outer tubular body lumen without occluding fluid flow therein under influence of an applied vacuum, and connected distally to said trailing end of said needle to provide a conduit including said needle lumen and said inner tubular body lumen, said inner tubular body sealingly exiting said outer tubular body proximately through said seal, and a filament received in said conduit.
an elongated outer tubular body having a lumen, a closed distal end, an aperture in a sidewall adjacent the closed end, a proximal inlet and a proximal branch for applying a vacuum thereto, a seal in said proximal inlet for sealing said outer tubular body to maintain an applied vacuum in said outer tubular body, a needle carrier arranged and moveable longitudinally in a distal portion of said outer tubular body without occluding flow communication from said aperture toward said branch under influence of an applied vacuum, limiter means in said outer tubular body distally of said branch and proximately of said closure for limiting distal and proximal longitudinal travel of said needle carrier, a needle having a lumen and carried in said needle carrier, said needle having a sharp leading end extending distally from said carrier and a trailing end extending proximately from said carrier, and having an opening adjacent said sharp leading end alignable with said aperture of said outer tubular body, an inner tubular body having a lumen and received in said outer tubular body lumen without occluding fluid flow therein under influence of an applied vacuum, and connected distally to said trailing end of said needle to provide a conduit including said needle lumen and said inner tubular body lumen, said inner tubular body sealingly exiting said outer tubular body proximately through said seal, and a filament received in said conduit.
20. The apparatus of claim 19 in which said limiter means comprise at least one constriction in said distal portion of said outer tubular body adjacent at least one end of and narrower than said needle carrier.
21. The apparatus of claim 19 in which said carrier includes a longitudinal recess having a distal end and a proximal end, at least one of which is blind, and wherein said limiter means comprise a stop extending transversely from said distal portion of said outer tubular body into said groove for impingement by said blind end or ends of said groove.
22. The apparatus of claim 21 in which said limiter means further comprise a constriction in said distal portion of said outer tubular body distal to and narrower than said needle carrier.
23. Use of the apparatus according to any one of claims 1 to 22, for accessing a pericardial space.
24. Use of the apparatus according to claim 3, for accessing a pericardial space, wherein said distal end is adapted to be observed fluroscopically.
25. Use of the apparatus according to claim 4, for accessing a pericardial space, wherein said lead is adapted to monitor the electrocardial signal of a heart to determine contact of the aperture of said tubular body with a pericardium.
26. The use according to claim 23, wherein said tubular body is adapted to detect a decrease in vacuum pressure marking capture of a pericardium in said aperture.
27. The use according to claim 23, wherein said tubular body is adapted to deliver a substance into the pericardial space.
28. The use according to claim 27, wherein said substance is a distal portion of a filament.
29. The use according to claim 28, wherein said distal portion of a filament is adapted to advance through said inner tubular body and into the pericardial space.
30. The use according to claim 29, wherein said distal portion of the filament is further adapted to remain in place in the pericardial space with a proximal portion inclusive of a proximal end of the filament remaining external to a patient body.
31. The use according to claim 30, wherein said filament is electro- or photo-conductive and is further adapted to regulate a heart.
32. The use according to claim 31, wherein said filament further comprises a defibrillator electrode.
33. The use according to claim 30, wherein said filament is hollow and provides an indwelling catheter to the pericardial space.
34. The use according to claim 27, wherein said substance is a bioactive cardiovascular drug.
35. The use according to claim 28, wherein said filament is a guidewire adapted to place a catheter into the pericardial space.
36. The use according to claim 35, wherein said catheter is adapted to deliver a bioactive substance into the pericardial space.
37. The use according to claim 36, wherein said bioactive substance is a solution of a bioactive cardiovascular drug.
38. The use according to claim 36, wherein the bioactive substance is selected from the group consisting of vasodilator, antiplatelet, anticoagulant, thrombolytic, anti-inflammatory, antiarrhythmic, inotropic, antimitotic, angiogenic, antiatherogenic and gene therapy agents.
39. The use according to claim 37, wherein the cardiovascular drug is selected from the group consisting of vasodilator, antiplatelet, anticoagulant, thrombolytic, anti-inflammatory, antiarrhythmic, inotropic, antimitotic, angiogenic, antiatherogenic and gene therapy agents.
40. The use according to claim 36, wherein the bioactive substance comprises a constrained release material.
41. The use according to claim 40, wherein the bioactive substance is comprised in one or more of a biopolymer, a biodegradable fiber, a liposome, a biodegradable polymeric microsphere, a paste, or a gel.
42. The use according to claim 33, wherein said indwelling catheter is adapted to deliver a bioactive substance into the pericardial space.
43. The use according to claim 42, wherein said bioactive substance is a solution of a bioactive cardiovascular drug.
44. The use according to claim 42, wherein the bioactive substance is selected from the group consisting of vasodilator, antiplatelet, anticoagulant, thrombolytic, anti-inflammatory, antiarrhythmic, inotropic, antimitotic, angiogenic, antiatherogenic and gene therapy agents.
45. The use according to claim 43, wherein the cardiovascular drug is selected from the group consisting of vasodilator, antiplatelet, anticoagulant, thrombolytic, anti-inflammatory, antiarrhythmic, inotropic, antimitotic, angiogenic, antiatherogenic and gene therapy agents.
46. The use according to claim 42, wherein the bioactive substance comprises a constrained release material.
47. The use according to claim 46, wherein the bioactive substance is comprised in one or more of a biopolymer, a biodegradable fiber, a liposome, a biodegradable polymeric microsphere, a paste, or a gel.
48. The use according to claim 33 or 35, wherein said catheter is adapted to withdraw fluid in said pericardial space.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/484,299 US5827216A (en) | 1995-06-07 | 1995-06-07 | Method and apparatus for accessing the pericardial space |
US08/484,299 | 1995-06-07 | ||
PCT/US1996/010442 WO1996040368A1 (en) | 1995-06-07 | 1996-06-07 | Method and apparatus for accessing the pericardial space |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2223954A1 CA2223954A1 (en) | 1996-12-19 |
CA2223954C true CA2223954C (en) | 2009-09-01 |
Family
ID=23923575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002223954A Expired - Fee Related CA2223954C (en) | 1995-06-07 | 1996-06-07 | Method and apparatus for accessing the pericardial space |
Country Status (6)
Country | Link |
---|---|
US (3) | US5827216A (en) |
EP (1) | EP0956094A4 (en) |
JP (1) | JP4005632B2 (en) |
AU (1) | AU6179996A (en) |
CA (1) | CA2223954C (en) |
WO (1) | WO1996040368A1 (en) |
Families Citing this family (364)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6161543A (en) | 1993-02-22 | 2000-12-19 | Epicor, Inc. | Methods of epicardial ablation for creating a lesion around the pulmonary veins |
US6409722B1 (en) | 1998-07-07 | 2002-06-25 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US5897553A (en) | 1995-11-02 | 1999-04-27 | Medtronic, Inc. | Ball point fluid-assisted electrocautery device |
US5904697A (en) | 1995-02-24 | 1999-05-18 | Heartport, Inc. | Devices and methods for performing a vascular anastomosis |
US5827216A (en) * | 1995-06-07 | 1998-10-27 | Cormedics Corp. | Method and apparatus for accessing the pericardial space |
US7445594B1 (en) | 1995-09-20 | 2008-11-04 | Medtronic, Inc. | Method and apparatus for temporarily immobilizing a local area of tissue |
US5836311A (en) | 1995-09-20 | 1998-11-17 | Medtronic, Inc. | Method and apparatus for temporarily immobilizing a local area of tissue |
US6719755B2 (en) | 1996-10-22 | 2004-04-13 | Epicor Medical, Inc. | Methods and devices for ablation |
US6805128B1 (en) | 1996-10-22 | 2004-10-19 | Epicor Medical, Inc. | Apparatus and method for ablating tissue |
US6311692B1 (en) | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US6237605B1 (en) | 1996-10-22 | 2001-05-29 | Epicor, Inc. | Methods of epicardial ablation |
US7052493B2 (en) | 1996-10-22 | 2006-05-30 | Epicor Medical, Inc. | Methods and devices for ablation |
US5931810A (en) * | 1996-12-05 | 1999-08-03 | Comedicus Incorporated | Method for accessing the pericardial space |
US6206004B1 (en) | 1996-12-06 | 2001-03-27 | Comedicus Incorporated | Treatment method via the pericardial space |
JP3036686B2 (en) * | 1997-02-27 | 2000-04-24 | 政夫 高橋 | Hemostatic holding device for vascular anastomosis used for coronary artery bypass surgery |
US6086582A (en) * | 1997-03-13 | 2000-07-11 | Altman; Peter A. | Cardiac drug delivery system |
US5968010A (en) * | 1997-04-30 | 1999-10-19 | Beth Israel Deaconess Medical Center, Inc. | Method for transvenously accessing the pericardial space via the right atrium |
US20040215168A1 (en) * | 1997-04-30 | 2004-10-28 | Beth Israel Deaconess Medical Center | Kit for transvenously accessing the pericardial space via the right atrium |
CA2241615A1 (en) * | 1997-06-26 | 1998-12-26 | An-Go-Gen Inc. | Catheters |
US6096037A (en) | 1997-07-29 | 2000-08-01 | Medtronic, Inc. | Tissue sealing electrosurgery device and methods of sealing tissue |
EP0893137B1 (en) * | 1997-07-22 | 2004-03-31 | Terumo Kabushiki Kaisha | Assembly for an indwelling catheter and method of making it |
US6592552B1 (en) * | 1997-09-19 | 2003-07-15 | Cecil C. Schmidt | Direct pericardial access device and method |
US8709007B2 (en) | 1997-10-15 | 2014-04-29 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Devices and methods for ablating cardiac tissue |
US5997509A (en) * | 1998-03-06 | 1999-12-07 | Cornell Research Foundation, Inc. | Minimally invasive gene therapy delivery device and method |
US6527767B2 (en) * | 1998-05-20 | 2003-03-04 | New England Medical Center | Cardiac ablation system and method for treatment of cardiac arrhythmias and transmyocardial revascularization |
US6231518B1 (en) | 1998-05-26 | 2001-05-15 | Comedicus Incorporated | Intrapericardial electrophysiological procedures |
US6537248B2 (en) | 1998-07-07 | 2003-03-25 | Medtronic, Inc. | Helical needle apparatus for creating a virtual electrode used for the ablation of tissue |
US6706039B2 (en) | 1998-07-07 | 2004-03-16 | Medtronic, Inc. | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
AU758587B2 (en) | 1998-09-15 | 2003-03-27 | Medtronic, Inc. | Method and apparatus for temporarily immobilizing a local area of tissue |
US8308719B2 (en) | 1998-09-21 | 2012-11-13 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Apparatus and method for ablating tissue |
US6251079B1 (en) | 1998-09-30 | 2001-06-26 | C. R. Bard, Inc. | Transthoracic drug delivery device |
US7185657B1 (en) | 1999-04-07 | 2007-03-06 | Johnson George M | Method and device for treating gastroesophageal reflux disease |
WO2000067825A1 (en) * | 1999-05-07 | 2000-11-16 | Microheart, Inc. | Apparatus and method for delivering therapeutic and diagnostic agents |
US6488689B1 (en) | 1999-05-20 | 2002-12-03 | Aaron V. Kaplan | Methods and apparatus for transpericardial left atrial appendage closure |
AU5595300A (en) | 1999-06-02 | 2000-12-18 | Microheart, Inc. | Devices and methods for delivering a drug |
US7147633B2 (en) | 1999-06-02 | 2006-12-12 | Boston Scientific Scimed, Inc. | Method and apparatus for treatment of atrial fibrillation |
CA2377583A1 (en) | 1999-07-19 | 2001-01-25 | Epicor, Inc. | Apparatus and method for ablating tissue |
US6569082B1 (en) | 1999-08-10 | 2003-05-27 | Origin Medsystems, Inc. | Apparatus and methods for cardiac restraint |
US20030187460A1 (en) * | 1999-08-10 | 2003-10-02 | Chin Albert K. | Methods and apparatus for endoscopic cardiac surgery |
US7264587B2 (en) * | 1999-08-10 | 2007-09-04 | Origin Medsystems, Inc. | Endoscopic subxiphoid surgical procedures |
US6423051B1 (en) * | 1999-09-16 | 2002-07-23 | Aaron V. Kaplan | Methods and apparatus for pericardial access |
US7758521B2 (en) * | 1999-10-29 | 2010-07-20 | Medtronic, Inc. | Methods and systems for accessing the pericardial space |
US20050154370A1 (en) | 1999-10-29 | 2005-07-14 | Medtronic, Inc. | Methods and systems for providing therapies into the pericardial space |
US20030093104A1 (en) * | 1999-10-29 | 2003-05-15 | Bonner Matthew D. | Methods and apparatus for providing intra-pericardial access |
US6613062B1 (en) | 1999-10-29 | 2003-09-02 | Medtronic, Inc. | Method and apparatus for providing intra-pericardial access |
US20040121942A1 (en) * | 1999-11-02 | 2004-06-24 | Kenneth Chien | Method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
AU3642401A (en) * | 1999-11-05 | 2001-05-14 | Microheart, Inc. | Method and apparatus for demand injury in stimulating angiogenesis |
US6676679B1 (en) | 1999-11-05 | 2004-01-13 | Boston Scientific Corporation | Method and apparatus for recurrent demand injury in stimulating angiogenesis |
US6748258B1 (en) | 1999-11-05 | 2004-06-08 | Scimed Life Systems, Inc. | Method and devices for heart treatment |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US7706882B2 (en) | 2000-01-19 | 2010-04-27 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area |
US8221402B2 (en) | 2000-01-19 | 2012-07-17 | Medtronic, Inc. | Method for guiding a medical device |
US7338434B1 (en) | 2002-08-21 | 2008-03-04 | Medtronic, Inc. | Method and system for organ positioning and stabilization |
US6478769B1 (en) | 2000-02-22 | 2002-11-12 | The Board Of Trustees Of The University Of Arkansas | Anatomical fluid evacuation apparatus and method |
US8048070B2 (en) | 2000-03-06 | 2011-11-01 | Salient Surgical Technologies, Inc. | Fluid-assisted medical devices, systems and methods |
US8083736B2 (en) | 2000-03-06 | 2011-12-27 | Salient Surgical Technologies, Inc. | Fluid-assisted medical devices, systems and methods |
WO2001070117A2 (en) | 2000-03-23 | 2001-09-27 | Microheart, Inc. | Pressure sensor for therapeutic delivery device and method |
US7214223B2 (en) * | 2000-03-24 | 2007-05-08 | Boston Scientific Scimed, Inc. | Photoatherolytic catheter apparatus and method |
US6398743B1 (en) | 2000-07-28 | 2002-06-04 | Mdc Investment Holdings, Inc. | Medical device for inserting a guide wire having a retractable needle |
BR0110158A (en) | 2000-04-18 | 2004-12-28 | Mdc Invest Holdings Inc | Medical device, and methods for infusing fluid into a patient with a medical device, for transfusing one of the blood and plasma into and out of a patient with a medical device, and for inserting a guide wire into a patient using a medical device. needle carrier doctor |
US6558382B2 (en) * | 2000-04-27 | 2003-05-06 | Medtronic, Inc. | Suction stabilized epicardial ablation devices |
US6514250B1 (en) | 2000-04-27 | 2003-02-04 | Medtronic, Inc. | Suction stabilized epicardial ablation devices |
AU2001253654A1 (en) | 2000-04-27 | 2001-11-12 | Medtronic, Inc. | Vibration sensitive ablation apparatus and method |
US8105351B2 (en) * | 2001-05-18 | 2012-01-31 | C.R. Bard, Inc. | Method of promoting tissue adhesion |
US6508802B1 (en) | 2000-05-23 | 2003-01-21 | Cornell Research Foundation, Inc. | Remote sensing gene therapy delivery device and method of administering a therapeutic solution to a heart |
US7588554B2 (en) | 2000-06-26 | 2009-09-15 | Boston Scientific Scimed, Inc. | Method and apparatus for treating ischemic tissue |
US6685672B1 (en) | 2000-07-13 | 2004-02-03 | Edwards Lifesciences Corporation | Multi-balloon drug delivery catheter for angiogenesis |
WO2002017809A1 (en) * | 2000-08-29 | 2002-03-07 | Kaplan Aaron V | Methods and apparatus for transpericardial left atrial appendage closure |
US6726920B1 (en) | 2000-09-22 | 2004-04-27 | Durect Corporation | Implantable drug delivery patch |
US6926669B1 (en) | 2000-10-10 | 2005-08-09 | Medtronic, Inc. | Heart wall ablation/mapping catheter and method |
AU2002227189A1 (en) * | 2000-10-30 | 2002-05-15 | Endonetics, Inc. | Method and device for treating gastroesophageal reflux disease |
US6692458B2 (en) | 2000-12-19 | 2004-02-17 | Edwards Lifesciences Corporation | Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis |
US6890295B2 (en) * | 2002-10-31 | 2005-05-10 | Medtronic, Inc. | Anatomical space access tools and methods |
US7146225B2 (en) * | 2002-10-30 | 2006-12-05 | Medtronic, Inc. | Methods and apparatus for accessing and stabilizing an area of the heart |
US6837848B2 (en) * | 2003-01-15 | 2005-01-04 | Medtronic, Inc. | Methods and apparatus for accessing and stabilizing an area of the heart |
US6676597B2 (en) | 2001-01-13 | 2004-01-13 | Medtronic, Inc. | Method and device for organ positioning |
US20040138621A1 (en) | 2003-01-14 | 2004-07-15 | Jahns Scott E. | Devices and methods for interstitial injection of biologic agents into tissue |
US6786898B2 (en) | 2003-01-15 | 2004-09-07 | Medtronic, Inc. | Methods and tools for accessing an anatomic space |
US7740623B2 (en) | 2001-01-13 | 2010-06-22 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US7357794B2 (en) | 2002-01-17 | 2008-04-15 | Medtronic Vascular, Inc. | Devices, systems and methods for acute or chronic delivery of substances or apparatus to extravascular treatment sites |
US6517275B2 (en) * | 2001-01-17 | 2003-02-11 | Walter H. Vail | Needle tube lock for tattoo machines |
CA2440387A1 (en) * | 2001-03-23 | 2002-10-03 | Durect Corporation | Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space |
US6663627B2 (en) | 2001-04-26 | 2003-12-16 | Medtronic, Inc. | Ablation system and method of use |
US6699240B2 (en) | 2001-04-26 | 2004-03-02 | Medtronic, Inc. | Method and apparatus for tissue ablation |
US6807968B2 (en) | 2001-04-26 | 2004-10-26 | Medtronic, Inc. | Method and system for treatment of atrial tachyarrhythmias |
US7959626B2 (en) | 2001-04-26 | 2011-06-14 | Medtronic, Inc. | Transmural ablation systems and methods |
US7702394B2 (en) | 2001-05-01 | 2010-04-20 | Intrapace, Inc. | Responsive gastric stimulator |
US20080065169A1 (en) * | 2001-05-01 | 2008-03-13 | Intrapace, Inc. | Endoscopic Instrument for Engaging a Device |
JP2003007916A (en) * | 2001-06-19 | 2003-01-10 | Sanyo Electric Co Ltd | Method of manufacturing circuit device |
US6702835B2 (en) | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20060052821A1 (en) | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
US6776784B2 (en) | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
US7429258B2 (en) * | 2001-10-26 | 2008-09-30 | Massachusetts Institute Of Technology | Microneedle transport device |
US20040230283A1 (en) * | 2001-11-29 | 2004-11-18 | Medtronic, Inc. | Trans-septal pacing method and apparatus |
US20080249504A1 (en) | 2007-04-06 | 2008-10-09 | Lattouf Omar M | Instrument port |
US6978176B2 (en) * | 2001-12-08 | 2005-12-20 | Lattouf Omar M | Treatment for patient with congestive heart failure |
US7967816B2 (en) | 2002-01-25 | 2011-06-28 | Medtronic, Inc. | Fluid-assisted electrosurgical instrument with shapeable electrode |
US7610104B2 (en) * | 2002-05-10 | 2009-10-27 | Cerebral Vascular Applications, Inc. | Methods and apparatus for lead placement on a surface of the heart |
US7118566B2 (en) | 2002-05-16 | 2006-10-10 | Medtronic, Inc. | Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue |
US7294143B2 (en) | 2002-05-16 | 2007-11-13 | Medtronic, Inc. | Device and method for ablation of cardiac tissue |
US7494460B2 (en) | 2002-08-21 | 2009-02-24 | Medtronic, Inc. | Methods and apparatus providing suction-assisted tissue engagement through a minimally invasive incision |
US7103418B2 (en) * | 2002-10-02 | 2006-09-05 | Medtronic, Inc. | Active fluid delivery catheter |
US7083620B2 (en) | 2002-10-30 | 2006-08-01 | Medtronic, Inc. | Electrosurgical hemostat |
WO2004043267A2 (en) | 2002-11-06 | 2004-05-27 | Medtronic, Inc. | Suction-assisted tissue engagement through a minimally invasive incision |
JP2006506211A (en) * | 2002-11-15 | 2006-02-23 | プレッシャー プロダクツ メディカル サプライズ インコーポレイテッド | Method and apparatus for attaching pacemaker lead wire |
US20050261673A1 (en) * | 2003-01-15 | 2005-11-24 | Medtronic, Inc. | Methods and apparatus for accessing and stabilizing an area of the heart |
US20040176788A1 (en) * | 2003-03-07 | 2004-09-09 | Nmt Medical, Inc. | Vacuum attachment system |
US7883500B2 (en) * | 2003-03-26 | 2011-02-08 | G&L Consulting, Llc | Method and system to treat and prevent myocardial infarct expansion |
US20040210240A1 (en) * | 2003-04-21 | 2004-10-21 | Sean Saint | Method and repair device for treating mitral valve insufficiency |
US7497857B2 (en) | 2003-04-29 | 2009-03-03 | Medtronic, Inc. | Endocardial dispersive electrode for use with a monopolar RF ablation pen |
DE10337813A1 (en) * | 2003-08-14 | 2005-03-10 | Transmit Technologietransfer | Device for tissue and organ manipulation |
US7691112B2 (en) | 2003-09-11 | 2010-04-06 | Nmt Medical, Inc. | Devices, systems, and methods for suturing tissue |
ES2700851T3 (en) | 2003-10-09 | 2019-02-19 | Sentreheart Inc | Apparatus for tissue binding |
US7666203B2 (en) | 2003-11-06 | 2010-02-23 | Nmt Medical, Inc. | Transseptal puncture apparatus |
US8292910B2 (en) | 2003-11-06 | 2012-10-23 | Pressure Products Medical Supplies, Inc. | Transseptal puncture apparatus |
EP1715792A2 (en) | 2004-01-30 | 2006-11-02 | NMT Medical, Inc. | Welding systems for closure of cardiac openings |
US8019437B2 (en) * | 2004-02-05 | 2011-09-13 | Medtronic, Inc. | Lead fixation means |
US7186214B2 (en) * | 2004-02-12 | 2007-03-06 | Medtronic, Inc. | Instruments and methods for accessing an anatomic space |
US7399272B2 (en) | 2004-03-24 | 2008-07-15 | Medtronic, Inc. | Methods and apparatus providing suction-assisted tissue engagement |
WO2005107765A2 (en) * | 2004-05-05 | 2005-11-17 | Cormedics Corporation | Heart treatment method |
US8333764B2 (en) | 2004-05-12 | 2012-12-18 | Medtronic, Inc. | Device and method for determining tissue thickness and creating cardiac ablation lesions |
ATE547990T1 (en) | 2004-05-14 | 2012-03-15 | Medtronic Inc | DEVICES FOR TREATING AFRICIA BY MASS ABLATION |
WO2005120376A2 (en) | 2004-06-02 | 2005-12-22 | Medtronic, Inc. | Ablation device with jaws |
EP1761188B1 (en) | 2004-06-02 | 2011-07-20 | Medtronic, Inc. | Clamping ablation tool |
WO2005120375A2 (en) | 2004-06-02 | 2005-12-22 | Medtronic, Inc. | Loop ablation apparatus and method |
ATE466536T1 (en) | 2004-06-02 | 2010-05-15 | Medtronic Inc | COMPOSITE BIPOLAR ABLATION DEVICE |
US8409219B2 (en) | 2004-06-18 | 2013-04-02 | Medtronic, Inc. | Method and system for placement of electrical lead inside heart |
US8926635B2 (en) * | 2004-06-18 | 2015-01-06 | Medtronic, Inc. | Methods and devices for occlusion of an atrial appendage |
US8663245B2 (en) | 2004-06-18 | 2014-03-04 | Medtronic, Inc. | Device for occlusion of a left atrial appendage |
US7678081B2 (en) * | 2004-07-12 | 2010-03-16 | Pacesetter, Inc. | Methods and devices for transseptal access |
US7556627B2 (en) * | 2004-09-13 | 2009-07-07 | Ethicon Endo-Surgery, Inc. | Mucosal ablation device |
US7618410B2 (en) * | 2004-10-05 | 2009-11-17 | Cardia Access, Inc. | Devices and methods for access through a tissue wall |
JP5026980B2 (en) * | 2004-11-18 | 2012-09-19 | ナノ パス テクノロジーズ リミテッド | Device for supplying fluid into a flexible biological barrier |
WO2006055820A2 (en) * | 2004-11-19 | 2006-05-26 | G & L Consulting Llc | Biodegradable pericardial constraint system and method |
US7226440B2 (en) * | 2005-01-31 | 2007-06-05 | G & L Consulting, Llc | Method and device for accessing a pericardial space |
US7918865B2 (en) | 2005-04-07 | 2011-04-05 | Sentreheart, Inc. | Apparatus and method for the ligation of tissue |
US20060259017A1 (en) * | 2005-04-27 | 2006-11-16 | Cardiac Pacemakers, Inc. | Adhesive elements and methods for accessing the pericardial space |
US7974710B2 (en) * | 2005-04-28 | 2011-07-05 | Medtronic, Inc. | Guide catheters for accessing cardiac sites |
US8500720B2 (en) * | 2005-05-09 | 2013-08-06 | Medtronic, Inc | Method and apparatus for treatment of cardiac disorders |
US8932208B2 (en) | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
US20070014784A1 (en) | 2005-06-23 | 2007-01-18 | Medtronic Vascular, Inc. | Methods and Systems for Treating Injured Cardiac Tissue |
US20070010793A1 (en) * | 2005-06-23 | 2007-01-11 | Cardiac Pacemakers, Inc. | Method and system for accessing a pericardial space |
WO2007005386A1 (en) * | 2005-06-30 | 2007-01-11 | Rox Medical, Inc. | Devices, systems, and methods for creation of a peripherally located fistula |
US8579936B2 (en) | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
US20070100199A1 (en) * | 2005-11-03 | 2007-05-03 | Lilip Lau | Apparatus and method of delivering biomaterial to the heart |
US7846179B2 (en) | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
US8518069B2 (en) | 2005-09-07 | 2013-08-27 | Cabochon Aesthetics, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US9011473B2 (en) | 2005-09-07 | 2015-04-21 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US9486274B2 (en) * | 2005-09-07 | 2016-11-08 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US9358033B2 (en) | 2005-09-07 | 2016-06-07 | Ulthera, Inc. | Fluid-jet dissection system and method for reducing the appearance of cellulite |
US10548659B2 (en) | 2006-01-17 | 2020-02-04 | Ulthera, Inc. | High pressure pre-burst for improved fluid delivery |
WO2007047813A2 (en) * | 2005-10-19 | 2007-04-26 | Ams Research Corporation | Needle delivery system for electrodes |
EP1944051A4 (en) * | 2005-10-31 | 2009-09-02 | Terumo Corp | Puncture device, dosing device and puncture method |
US8182444B2 (en) * | 2005-11-04 | 2012-05-22 | Medrad, Inc. | Delivery of agents such as cells to tissue |
US7713232B2 (en) * | 2005-11-04 | 2010-05-11 | Medrad, Inc. | System for washing and processing of cells for delivery thereof to tissue |
US20070156096A1 (en) * | 2005-11-10 | 2007-07-05 | Terumo Kabushiki Kaisha | Puncture device |
AU2006315601A1 (en) * | 2005-11-14 | 2007-05-24 | Enterprise Partners Venture Capital | Stem cell factor therapy for tissue injury |
US20070119461A1 (en) * | 2005-11-18 | 2007-05-31 | Brian Biancucci | Article isolation device and methods |
US9248317B2 (en) | 2005-12-02 | 2016-02-02 | Ulthera, Inc. | Devices and methods for selectively lysing cells |
US7885793B2 (en) | 2007-05-22 | 2011-02-08 | International Business Machines Corporation | Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution |
US20070185502A1 (en) * | 2005-12-29 | 2007-08-09 | Karel Smits | Medical electrode delivery tool |
US20070239247A1 (en) * | 2006-03-30 | 2007-10-11 | Camps Antoine N | Medical electrical lead and delivery system |
US9005220B2 (en) * | 2006-04-04 | 2015-04-14 | C.R. Bard, Inc. | Suturing devices and methods with energy emitting elements |
US7729783B2 (en) | 2006-04-26 | 2010-06-01 | Medtronic, Inc. | Apparatus and methods for vacuum- and mechanically-assisted fixation of medical electrical leads |
US8244379B2 (en) * | 2006-04-26 | 2012-08-14 | Medtronic, Inc. | Pericardium fixation concepts of epicardium pacing leads and tools |
US7794387B2 (en) | 2006-04-26 | 2010-09-14 | Medtronic, Inc. | Methods and devices for stabilizing tissue |
US8147397B1 (en) * | 2006-05-19 | 2012-04-03 | Carbon Medical Technologies, Inc. | Urethral needle guide device |
US20080039746A1 (en) | 2006-05-25 | 2008-02-14 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
CA2656341C (en) * | 2006-06-30 | 2015-12-29 | Cvdevices, Llc | Percutaneous intravascular access to cardiac tissue |
US20080086111A1 (en) * | 2006-10-09 | 2008-04-10 | Medrad, Inc. | Fluid delivery systems and volume metering in cell delivery |
US9993639B2 (en) * | 2006-10-31 | 2018-06-12 | Medtronic, Inc. | Implantable medical elongated member including a tissue receiving fixation cavity |
DE102006058447A1 (en) * | 2006-12-10 | 2008-06-19 | Philipps-Universität Marburg | Device for fixation and manipulation of organic or inorganic tissues |
US10166070B2 (en) * | 2007-01-02 | 2019-01-01 | Baylis Medical Company Inc. | Electrosurgical pericardial puncture |
US20080171989A1 (en) * | 2007-01-16 | 2008-07-17 | Bell Stephen G | Trans Urinary Bladder Access Device and Method |
WO2008112870A2 (en) | 2007-03-13 | 2008-09-18 | University Of Virginia Patent Foundation | Epicardial ablation catheter and method of use |
US9468396B2 (en) | 2007-03-19 | 2016-10-18 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
US8282565B2 (en) * | 2007-03-19 | 2012-10-09 | University Of Virginia Patent Foundation | Access needle pressure sensor device and method of use |
US11058354B2 (en) | 2007-03-19 | 2021-07-13 | University Of Virginia Patent Foundation | Access needle with direct visualization and related methods |
US9211405B2 (en) * | 2007-03-22 | 2015-12-15 | University Of Virginia Patent Foundation | Electrode catheter for ablation purposes and related method thereof |
DK2574287T3 (en) | 2007-03-30 | 2015-07-27 | Sentreheart Inc | Devices for closing the left forkammervedhæng |
CN101790395B (en) * | 2007-04-23 | 2013-09-25 | Sid科技有限责任公司 | Methods and devices for intradermal injection |
US20080294174A1 (en) * | 2007-05-21 | 2008-11-27 | Epitek, Inc. | Methods and apparatus for pericardial access |
ES2628732T3 (en) | 2007-09-20 | 2017-08-03 | Sentreheart, Inc. | Devices and methods for remote suture management. |
EP2209517A4 (en) | 2007-10-05 | 2011-03-30 | Maquet Cardiovascular Llc | Devices and methods for minimally-invasive surgical procedures |
US8439940B2 (en) | 2010-12-22 | 2013-05-14 | Cabochon Aesthetics, Inc. | Dissection handpiece with aspiration means for reducing the appearance of cellulite |
US20100241185A1 (en) | 2007-11-09 | 2010-09-23 | University Of Virginia Patent Foundation | Steerable epicardial pacing catheter system placed via the subxiphoid process |
US8663321B2 (en) * | 2007-12-06 | 2014-03-04 | L. Van Thomas Crisco | Minimally invasive method for coronary bypass and other treatments |
US20200352647A1 (en) * | 2007-12-27 | 2020-11-12 | Baylis Medical Company Inc. | Electrosurgical Pericardial Puncture |
WO2009086448A1 (en) | 2007-12-28 | 2009-07-09 | Salient Surgical Technologies, Inc. | Fluid-assisted electrosurgical devices, methods and systems |
US20100331854A1 (en) * | 2008-01-07 | 2010-12-30 | Ilan Greenberg | Device and method for performing treatment in a pericardial space |
WO2009140359A2 (en) | 2008-05-13 | 2009-11-19 | Medtronic, Inc. | Tissue lesion evaluation |
US8313493B2 (en) * | 2008-07-10 | 2012-11-20 | Cook Medical Technologies Llc | Hydraulic guidewire advancement system |
JP5265295B2 (en) * | 2008-10-10 | 2013-08-14 | オリンパス株式会社 | Heart sheath |
CN102307612B (en) * | 2008-12-08 | 2015-01-07 | Sid技术有限责任公司 | Alignment of a needle in an intradermal injection device |
US9393023B2 (en) | 2009-01-13 | 2016-07-19 | Atricure, Inc. | Apparatus and methods for deploying a clip to occlude an anatomical structure |
US9254168B2 (en) | 2009-02-02 | 2016-02-09 | Medtronic Advanced Energy Llc | Electro-thermotherapy of tissue using penetrating microelectrode array |
JP5592409B2 (en) | 2009-02-23 | 2014-09-17 | サリエント・サージカル・テクノロジーズ・インコーポレーテッド | Fluid-assisted electrosurgical device and method of use thereof |
JP5415925B2 (en) | 2009-03-02 | 2014-02-12 | オリンパス株式会社 | Endoscope |
US20100234827A1 (en) * | 2009-03-13 | 2010-09-16 | Sigg Daniel C | Method of treating heart failure |
CN104688284B9 (en) | 2009-04-01 | 2018-03-09 | 森特莱哈尔特公司 | tissue ligation device and controller thereof |
US20100274129A1 (en) * | 2009-04-24 | 2010-10-28 | Hooven Michael D | Apparatus And Methods for Separating Pericardial Tissue From The Epicardium of the Heart |
US8906056B2 (en) | 2009-05-01 | 2014-12-09 | University Of Virginia Patent Foundation | Access trocar and related method thereof |
US9089655B2 (en) | 2009-07-23 | 2015-07-28 | Sid Technologies, Llc | Intradermal injection adapter |
US9358064B2 (en) | 2009-08-07 | 2016-06-07 | Ulthera, Inc. | Handpiece and methods for performing subcutaneous surgery |
US11096708B2 (en) | 2009-08-07 | 2021-08-24 | Ulthera, Inc. | Devices and methods for performing subcutaneous surgery |
WO2011031748A1 (en) | 2009-09-08 | 2011-03-17 | Salient Surgical Technologies, Inc. | Cartridge assembly for electrosurgical devices, electrosurgical unit and methods of use thereof |
US9642534B2 (en) | 2009-09-11 | 2017-05-09 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
JP5567840B2 (en) | 2009-09-22 | 2014-08-06 | オリンパス株式会社 | Cell injection device |
EP2481377A4 (en) | 2009-09-22 | 2017-12-20 | Olympus Corporation | Space-securing device |
JP5508804B2 (en) | 2009-10-06 | 2014-06-04 | オリンパス株式会社 | Guide device |
US8343106B2 (en) | 2009-12-23 | 2013-01-01 | Alcon Research, Ltd. | Ophthalmic valved trocar vent |
US8277418B2 (en) | 2009-12-23 | 2012-10-02 | Alcon Research, Ltd. | Ophthalmic valved trocar cannula |
JP2011147758A (en) * | 2010-01-22 | 2011-08-04 | Olympus Corp | Treatment instrument |
US9218752B2 (en) | 2010-02-18 | 2015-12-22 | University Of Virginia Patent Foundation | System, method, and computer program product for simulating epicardial electrophysiology procedures |
US20110218528A1 (en) * | 2010-03-05 | 2011-09-08 | Retro Vascular, Inc. | Anatomical structure access and penetration |
EP2544616B1 (en) | 2010-03-11 | 2017-09-06 | Medtronic Advanced Energy LLC | Bipolar electrosurgical cutter with position insensitive return electrode contact |
ES2575546T3 (en) * | 2010-03-12 | 2016-06-29 | Sid Technologies Llc | Set for use with a syringe |
US8795310B2 (en) | 2010-04-13 | 2014-08-05 | Sentreheart, Inc. | Methods and devices for accessing and delivering devices to a heart |
US8986278B2 (en) | 2010-04-13 | 2015-03-24 | Sentreheart, Inc. | Methods and devices for pericardial access |
US9242122B2 (en) | 2010-05-14 | 2016-01-26 | Liat Tsoref | Reflectance-facilitated ultrasound treatment and monitoring |
US8956346B2 (en) | 2010-05-14 | 2015-02-17 | Rainbow Medical, Ltd. | Reflectance-facilitated ultrasound treatment and monitoring |
US8617150B2 (en) | 2010-05-14 | 2013-12-31 | Liat Tsoref | Reflectance-facilitated ultrasound treatment |
US20110295249A1 (en) * | 2010-05-28 | 2011-12-01 | Salient Surgical Technologies, Inc. | Fluid-Assisted Electrosurgical Devices, and Methods of Manufacture Thereof |
US9138289B2 (en) | 2010-06-28 | 2015-09-22 | Medtronic Advanced Energy Llc | Electrode sheath for electrosurgical device |
US8906012B2 (en) | 2010-06-30 | 2014-12-09 | Medtronic Advanced Energy Llc | Electrosurgical devices with wire electrode |
US8920417B2 (en) | 2010-06-30 | 2014-12-30 | Medtronic Advanced Energy Llc | Electrosurgical devices and methods of use thereof |
CN103025378B (en) | 2010-07-13 | 2015-10-07 | 蓝带技术公司 | With the method and apparatus of Rhizoma Atractylodis Macrocephalae cardiac tissue injection |
US8346373B2 (en) | 2010-08-03 | 2013-01-01 | Medtronic, Inc. | Method and apparatus for delivering a lead to a heart |
WO2012045030A2 (en) | 2010-10-01 | 2012-04-05 | Intrapace, Inc. | Feedback systems and methods to enhance obstructive and other obesity treatments, optionally using multiple sensors |
US9023040B2 (en) | 2010-10-26 | 2015-05-05 | Medtronic Advanced Energy Llc | Electrosurgical cutting devices |
US9017349B2 (en) | 2010-10-27 | 2015-04-28 | Atricure, Inc. | Appendage clamp deployment assist device |
US8636754B2 (en) | 2010-11-11 | 2014-01-28 | Atricure, Inc. | Clip applicator |
US8771173B2 (en) | 2010-12-14 | 2014-07-08 | Saint Joseph's Translational Research Institute, Inc. | Access device for surgery |
EP2489379B1 (en) | 2011-01-21 | 2020-09-23 | SID Technologies, LLC | Intradermal pen adapter |
US9427281B2 (en) | 2011-03-11 | 2016-08-30 | Medtronic Advanced Energy Llc | Bronchoscope-compatible catheter provided with electrosurgical device |
US20120232564A1 (en) * | 2011-03-11 | 2012-09-13 | Greatbatch Ltd. | Epidural needle for spinal cord stimulation |
US8628552B2 (en) | 2011-03-16 | 2014-01-14 | Pacesetter, Inc. | Apparatus and method for accessing an intrapericardial space |
JP5955838B2 (en) | 2011-04-28 | 2016-07-20 | テルモ株式会社 | Injection needle assembly and drug injection device |
US9962500B2 (en) * | 2011-04-28 | 2018-05-08 | Sanofi-Aventis Deutschland Gmbh | Connection for medical device |
BR112013031390A2 (en) | 2011-06-08 | 2016-12-06 | Sentreheart Inc | fabric binding devices and tensioning devices therefor |
US8893278B1 (en) | 2011-07-12 | 2014-11-18 | Trustwave Holdings, Inc. | Detecting malware communication on an infected computing device |
US9750565B2 (en) | 2011-09-30 | 2017-09-05 | Medtronic Advanced Energy Llc | Electrosurgical balloons |
US8870864B2 (en) | 2011-10-28 | 2014-10-28 | Medtronic Advanced Energy Llc | Single instrument electrosurgery apparatus and its method of use |
US9707414B2 (en) | 2012-02-14 | 2017-07-18 | Rainbow Medical Ltd. | Reflectance-facilitated ultrasound treatment and monitoring |
US9821145B2 (en) | 2012-03-23 | 2017-11-21 | Pressure Products Medical Supplies Inc. | Transseptal puncture apparatus and method for using the same |
US9226792B2 (en) | 2012-06-12 | 2016-01-05 | Medtronic Advanced Energy Llc | Debridement device and method |
JP5941776B2 (en) * | 2012-07-13 | 2016-06-29 | オリンパス株式会社 | Guide wire introduction device |
JP5941775B2 (en) * | 2012-07-13 | 2016-06-29 | オリンパス株式会社 | Guide wire introduction device |
US8834506B2 (en) | 2012-09-24 | 2014-09-16 | Fawaz ALHUMAID | Method for puncturing the pericardial membrane by synchronizing needle advancement with cardiac muscle motion |
US11234760B2 (en) | 2012-10-05 | 2022-02-01 | Medtronic Advanced Energy Llc | Electrosurgical device for cutting and removing tissue |
US9339295B2 (en) | 2012-10-22 | 2016-05-17 | Sentreheart, Inc. | Pericardial access devices and methods |
CN107334525B (en) | 2012-11-05 | 2019-10-08 | 毕达哥拉斯医疗有限公司 | Controlled tissue ablation |
US9770593B2 (en) | 2012-11-05 | 2017-09-26 | Pythagoras Medical Ltd. | Patient selection using a transluminally-applied electric current |
EP2939619B1 (en) * | 2012-12-28 | 2020-02-12 | Synaptic Medical (Beijing) Co. Ltd. | Pericardium puncture needle assembly |
CA2902064C (en) | 2013-03-12 | 2021-06-01 | Sentreheart, Inc. | Tissue ligation devices and methods therefor |
US9474865B2 (en) | 2013-04-25 | 2016-10-25 | West Pharmaceutical Services, Inc. | Needle shield for disposable syringe with annular ring |
JP6128951B2 (en) * | 2013-05-17 | 2017-05-17 | オリンパス株式会社 | Guide device |
BR112015029211A2 (en) | 2013-05-24 | 2017-07-25 | Bioventrix Inc | cardiac tissue penetration devices, methods, and systems for treating congestive heart failure and other conditions |
US9326793B2 (en) | 2013-07-16 | 2016-05-03 | Fawaz ALHUMAID | Needle for physically separating and penetrating the pericardium |
AU2014312242A1 (en) | 2013-08-30 | 2016-03-10 | Bioventrix, Inc. | Cardiac tissue anchoring devices, methods, and systems for treatment of congestive heart failure and other conditions |
EP3062711B1 (en) | 2013-10-31 | 2023-06-21 | AtriCure, Inc. | Devices for left atrial appendage closure |
US10314647B2 (en) | 2013-12-23 | 2019-06-11 | Medtronic Advanced Energy Llc | Electrosurgical cutting instrument |
WO2015106007A1 (en) | 2014-01-10 | 2015-07-16 | Cardiac Pacemakers, Inc. | Methods and systems for improved communication between medical devices |
EP3092034B1 (en) | 2014-01-10 | 2019-10-30 | Cardiac Pacemakers, Inc. | Systems for detecting cardiac arrhythmias |
US10813686B2 (en) | 2014-02-26 | 2020-10-27 | Medtronic Advanced Energy Llc | Electrosurgical cutting instrument |
CA2939929C (en) | 2014-02-28 | 2023-04-11 | Sentreheart, Inc. | Pericardial access devices and methods |
US10478249B2 (en) | 2014-05-07 | 2019-11-19 | Pythagoras Medical Ltd. | Controlled tissue ablation techniques |
US10842988B2 (en) * | 2014-06-02 | 2020-11-24 | Medtronic, Inc. | Over-the-wire delivery of a substernal lead |
US9974599B2 (en) | 2014-08-15 | 2018-05-22 | Medtronic Ps Medical, Inc. | Multipurpose electrosurgical device |
EP3185952B1 (en) | 2014-08-28 | 2018-07-25 | Cardiac Pacemakers, Inc. | Implantable cardiac rhythm system and an associated method for triggering a blanking period through a second device |
AU2016215606B2 (en) | 2015-02-06 | 2018-05-31 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
US10220213B2 (en) | 2015-02-06 | 2019-03-05 | Cardiac Pacemakers, Inc. | Systems and methods for safe delivery of electrical stimulation therapy |
US10046167B2 (en) | 2015-02-09 | 2018-08-14 | Cardiac Pacemakers, Inc. | Implantable medical device with radiopaque ID tag |
US10188456B2 (en) | 2015-02-18 | 2019-01-29 | Medtronic Xomed, Inc. | Electrode assembly for RF energy enabled tissue debridement device |
WO2016134156A1 (en) | 2015-02-18 | 2016-08-25 | Medtronic Xomed, Inc. | Rf energy enabled tissue debridement device |
US10376302B2 (en) | 2015-02-18 | 2019-08-13 | Medtronic Xomed, Inc. | Rotating electrical connector for RF energy enabled tissue debridement device |
WO2016141046A1 (en) | 2015-03-04 | 2016-09-09 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
JP6515195B2 (en) | 2015-03-18 | 2019-05-15 | カーディアック ペースメイカーズ, インコーポレイテッド | Implantable medical device and medical system |
US10050700B2 (en) | 2015-03-18 | 2018-08-14 | Cardiac Pacemakers, Inc. | Communications in a medical device system with temporal optimization |
WO2016154498A1 (en) | 2015-03-24 | 2016-09-29 | Sentreheart, Inc. | Devices and methods for left atrial appendage closure |
CN104740695A (en) * | 2015-03-24 | 2015-07-01 | 张家亮 | Puncture type drainage and dosage dual-purpose device of medical department |
WO2016154488A2 (en) | 2015-03-24 | 2016-09-29 | Sentreheart, Inc. | Tissue ligation devices and methods therefor |
US10383685B2 (en) | 2015-05-07 | 2019-08-20 | Pythagoras Medical Ltd. | Techniques for use with nerve tissue |
US11389227B2 (en) | 2015-08-20 | 2022-07-19 | Medtronic Advanced Energy Llc | Electrosurgical device with multivariate control |
WO2017031221A1 (en) | 2015-08-20 | 2017-02-23 | Cardiac Pacemakers, Inc. | Systems and methods for communication between medical devices |
CN108136187B (en) | 2015-08-20 | 2021-06-29 | 心脏起搏器股份公司 | System and method for communication between medical devices |
US11051875B2 (en) | 2015-08-24 | 2021-07-06 | Medtronic Advanced Energy Llc | Multipurpose electrosurgical device |
US9956414B2 (en) | 2015-08-27 | 2018-05-01 | Cardiac Pacemakers, Inc. | Temporal configuration of a motion sensor in an implantable medical device |
US9968787B2 (en) | 2015-08-27 | 2018-05-15 | Cardiac Pacemakers, Inc. | Spatial configuration of a motion sensor in an implantable medical device |
US10226631B2 (en) | 2015-08-28 | 2019-03-12 | Cardiac Pacemakers, Inc. | Systems and methods for infarct detection |
US10137305B2 (en) | 2015-08-28 | 2018-11-27 | Cardiac Pacemakers, Inc. | Systems and methods for behaviorally responsive signal detection and therapy delivery |
WO2017040115A1 (en) | 2015-08-28 | 2017-03-09 | Cardiac Pacemakers, Inc. | System for detecting tamponade |
CN108024694B (en) | 2015-09-09 | 2021-04-27 | 贝利斯医疗公司 | Epicardial access systems and methods |
US10092760B2 (en) | 2015-09-11 | 2018-10-09 | Cardiac Pacemakers, Inc. | Arrhythmia detection and confirmation |
EP3359251B1 (en) | 2015-10-08 | 2019-08-07 | Cardiac Pacemakers, Inc. | Adjusting pacing rates in an implantable medical device |
US10327812B2 (en) | 2015-11-04 | 2019-06-25 | Rainbow Medical Ltd. | Pericardial access device |
BR112018010622B1 (en) | 2015-11-25 | 2023-04-11 | Talon Medical, LLC | FABRIC COUPLING DEVICE AND KIT |
US10183170B2 (en) | 2015-12-17 | 2019-01-22 | Cardiac Pacemakers, Inc. | Conducted communication in a medical device system |
US10716612B2 (en) | 2015-12-18 | 2020-07-21 | Medtronic Advanced Energy Llc | Electrosurgical device with multiple monopolar electrode assembly |
US10905886B2 (en) | 2015-12-28 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device for deployment across the atrioventricular septum |
CN105457148B (en) * | 2016-01-18 | 2019-01-18 | 浙江大学 | A kind of pericardium injection medicament administration device and its method |
US10583303B2 (en) | 2016-01-19 | 2020-03-10 | Cardiac Pacemakers, Inc. | Devices and methods for wirelessly recharging a rechargeable battery of an implantable medical device |
CN109069840B (en) | 2016-02-04 | 2022-03-15 | 心脏起搏器股份公司 | Delivery system with force sensor for leadless cardiac devices |
JP7137472B2 (en) | 2016-02-26 | 2022-09-14 | センターハート・インコーポレイテッド | Device and method for left atrial appendage closure |
CN108883286B (en) | 2016-03-31 | 2021-12-07 | 心脏起搏器股份公司 | Implantable medical device with rechargeable battery |
US10668294B2 (en) | 2016-05-10 | 2020-06-02 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker configured for over the wire delivery |
US10328272B2 (en) | 2016-05-10 | 2019-06-25 | Cardiac Pacemakers, Inc. | Retrievability for implantable medical devices |
WO2017199240A2 (en) | 2016-05-18 | 2017-11-23 | Pythagoras Medical Ltd. | Helical catheter |
WO2018005373A1 (en) | 2016-06-27 | 2018-01-04 | Cardiac Pacemakers, Inc. | Cardiac therapy system using subcutaneously sensed p-waves for resynchronization pacing management |
US11207527B2 (en) | 2016-07-06 | 2021-12-28 | Cardiac Pacemakers, Inc. | Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
WO2018009392A1 (en) | 2016-07-07 | 2018-01-11 | Cardiac Pacemakers, Inc. | Leadless pacemaker using pressure measurements for pacing capture verification |
WO2018017226A1 (en) | 2016-07-20 | 2018-01-25 | Cardiac Pacemakers, Inc. | System for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
WO2018035343A1 (en) | 2016-08-19 | 2018-02-22 | Cardiac Pacemakers, Inc. | Trans septal implantable medical device |
EP3503970B1 (en) | 2016-08-24 | 2023-01-04 | Cardiac Pacemakers, Inc. | Cardiac resynchronization using fusion promotion for timing management |
US10780278B2 (en) | 2016-08-24 | 2020-09-22 | Cardiac Pacemakers, Inc. | Integrated multi-device cardiac resynchronization therapy using P-wave to pace timing |
WO2018057626A1 (en) | 2016-09-21 | 2018-03-29 | Cardiac Pacemakers, Inc. | Implantable cardiac monitor |
US10758737B2 (en) | 2016-09-21 | 2020-09-01 | Cardiac Pacemakers, Inc. | Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter |
WO2018057318A1 (en) | 2016-09-21 | 2018-03-29 | Cardiac Pacemakers, Inc. | Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery |
JP7038115B2 (en) | 2016-10-27 | 2022-03-17 | カーディアック ペースメイカーズ, インコーポレイテッド | Implantable medical device with pressure sensor |
US10413733B2 (en) | 2016-10-27 | 2019-09-17 | Cardiac Pacemakers, Inc. | Implantable medical device with gyroscope |
EP3532160B1 (en) | 2016-10-27 | 2023-01-25 | Cardiac Pacemakers, Inc. | Separate device in managing the pace pulse energy of a cardiac pacemaker |
EP3532159B1 (en) | 2016-10-27 | 2021-12-22 | Cardiac Pacemakers, Inc. | Implantable medical device delivery system with integrated sensor |
US10561330B2 (en) | 2016-10-27 | 2020-02-18 | Cardiac Pacemakers, Inc. | Implantable medical device having a sense channel with performance adjustment |
WO2018081275A1 (en) | 2016-10-27 | 2018-05-03 | Cardiac Pacemakers, Inc. | Multi-device cardiac resynchronization therapy with timing enhancements |
WO2018081713A1 (en) | 2016-10-31 | 2018-05-03 | Cardiac Pacemakers, Inc | Systems for activity level pacing |
CN109952128B (en) | 2016-10-31 | 2023-06-13 | 心脏起搏器股份公司 | System for activity level pacing |
WO2018089311A1 (en) | 2016-11-08 | 2018-05-17 | Cardiac Pacemakers, Inc | Implantable medical device for atrial deployment |
EP3538213B1 (en) | 2016-11-09 | 2023-04-12 | Cardiac Pacemakers, Inc. | Systems and devices for setting cardiac pacing pulse parameters for a cardiac pacing device |
US10881869B2 (en) | 2016-11-21 | 2021-01-05 | Cardiac Pacemakers, Inc. | Wireless re-charge of an implantable medical device |
EP3541471B1 (en) | 2016-11-21 | 2021-01-20 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker providing cardiac resynchronization therapy |
US10639486B2 (en) | 2016-11-21 | 2020-05-05 | Cardiac Pacemakers, Inc. | Implantable medical device with recharge coil |
WO2018094342A1 (en) | 2016-11-21 | 2018-05-24 | Cardiac Pacemakers, Inc | Implantable medical device with a magnetically permeable housing and an inductive coil disposed about the housing |
EP3541473B1 (en) | 2016-11-21 | 2020-11-11 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with multimode communication |
US11207532B2 (en) | 2017-01-04 | 2021-12-28 | Cardiac Pacemakers, Inc. | Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system |
CN110198759B (en) | 2017-01-26 | 2023-08-11 | 心脏起搏器股份公司 | Leadless implantable device with removable fasteners |
AU2018213326B2 (en) | 2017-01-26 | 2020-09-10 | Cardiac Pacemakers, Inc. | Intra-body device communication with redundant message transmission |
WO2018140623A1 (en) | 2017-01-26 | 2018-08-02 | Cardiac Pacemakers, Inc. | Leadless device with overmolded components |
US10905872B2 (en) | 2017-04-03 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device with a movable electrode biased toward an extended position |
CN110740779B (en) | 2017-04-03 | 2024-03-08 | 心脏起搏器股份公司 | Cardiac pacemaker with pacing pulse energy modulation based on sensed heart rate |
US10918875B2 (en) | 2017-08-18 | 2021-02-16 | Cardiac Pacemakers, Inc. | Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator |
EP3668592B1 (en) | 2017-08-18 | 2021-11-17 | Cardiac Pacemakers, Inc. | Implantable medical device with pressure sensor |
WO2019060302A1 (en) | 2017-09-20 | 2019-03-28 | Cardiac Pacemakers, Inc. | Implantable medical device with multiple modes of operation |
US11185703B2 (en) | 2017-11-07 | 2021-11-30 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker for bundle of his pacing |
US10667842B2 (en) | 2017-11-24 | 2020-06-02 | Rainbow Medical Ltd. | Pericardial needle mechanism |
US11813463B2 (en) | 2017-12-01 | 2023-11-14 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with reversionary behavior |
US11052258B2 (en) | 2017-12-01 | 2021-07-06 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials within a search window from a ventricularly implanted leadless cardiac pacemaker |
US11071870B2 (en) | 2017-12-01 | 2021-07-27 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker |
US11260216B2 (en) | 2017-12-01 | 2022-03-01 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials during ventricular filling from a ventricularly implanted leadless cardiac pacemaker |
US11529523B2 (en) | 2018-01-04 | 2022-12-20 | Cardiac Pacemakers, Inc. | Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone |
CN111556773A (en) | 2018-01-04 | 2020-08-18 | 心脏起搏器股份公司 | Dual chamber pacing without beat-to-beat communication |
US11400296B2 (en) | 2018-03-23 | 2022-08-02 | Medtronic, Inc. | AV synchronous VfA cardiac therapy |
JP2021518192A (en) | 2018-03-23 | 2021-08-02 | メドトロニック,インコーポレイテッド | VfA cardiac resynchronization therapy |
JP2021519117A (en) | 2018-03-23 | 2021-08-10 | メドトロニック,インコーポレイテッド | VfA Cardiac Treatment for Tachycardia |
CN112770807A (en) | 2018-09-26 | 2021-05-07 | 美敦力公司 | Capture in atrial-to-ventricular cardiac therapy |
US11951313B2 (en) | 2018-11-17 | 2024-04-09 | Medtronic, Inc. | VFA delivery systems and methods |
US11779390B2 (en) | 2018-12-26 | 2023-10-10 | Biosense Webster (Israel) Ltd. | Pericardium catheter including camera for guiding cutting through pericardium |
US11679265B2 (en) | 2019-02-14 | 2023-06-20 | Medtronic, Inc. | Lead-in-lead systems and methods for cardiac therapy |
US11697025B2 (en) | 2019-03-29 | 2023-07-11 | Medtronic, Inc. | Cardiac conduction system capture |
US11213676B2 (en) | 2019-04-01 | 2022-01-04 | Medtronic, Inc. | Delivery systems for VfA cardiac therapy |
US11712188B2 (en) | 2019-05-07 | 2023-08-01 | Medtronic, Inc. | Posterior left bundle branch engagement |
US11305127B2 (en) | 2019-08-26 | 2022-04-19 | Medtronic Inc. | VfA delivery and implant region detection |
US11813466B2 (en) | 2020-01-27 | 2023-11-14 | Medtronic, Inc. | Atrioventricular nodal stimulation |
US11911168B2 (en) | 2020-04-03 | 2024-02-27 | Medtronic, Inc. | Cardiac conduction system therapy benefit determination |
US11813464B2 (en) | 2020-07-31 | 2023-11-14 | Medtronic, Inc. | Cardiac conduction system evaluation |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3844272A (en) * | 1969-02-14 | 1974-10-29 | A Banko | Surgical instruments |
US3630207A (en) * | 1969-08-08 | 1971-12-28 | Cutter Lab | Pericardial catheter |
US3804097A (en) * | 1972-12-14 | 1974-04-16 | P Rudie | Method of irrigating and treating an abcess |
US4003379A (en) * | 1974-04-23 | 1977-01-18 | Ellinwood Jr Everett H | Apparatus and method for implanted self-powered medication dispensing |
US3923060A (en) * | 1974-04-23 | 1975-12-02 | Jr Everett H Ellinwood | Apparatus and method for implanted self-powered medication dispensing having timing and evaluator means |
US4027510A (en) * | 1974-05-15 | 1977-06-07 | Siegfried Hiltebrandt | Forceps |
US4230123A (en) * | 1978-10-31 | 1980-10-28 | Hawkins Jr Irvin F | Needle sheath complex and process for decompression and biopsy |
US4249541A (en) * | 1979-04-26 | 1981-02-10 | David S. Pratt | Biopsy device |
US4578061A (en) * | 1980-10-28 | 1986-03-25 | Lemelson Jerome H | Injection catheter and method |
SE426023B (en) * | 1981-04-23 | 1982-12-06 | Bengt Gustavsson | DEVICE BLA FOR INFANTRY OF CATHEDRES IN BLOOD BLOOD |
US4759348A (en) * | 1981-09-28 | 1988-07-26 | Cawood Charles David | Endoscope assembly and surgical instrument for use therewith |
US4464171A (en) * | 1982-03-29 | 1984-08-07 | Garwin Mark J | Intravascular insertion apparatus and method |
DE3327585A1 (en) * | 1982-08-06 | 1984-02-09 | John Martin Oxford Evans | SURGICAL INSTRUMENT FOR EPIDURAL AND SPINAL ANESTHESIA |
US4540404A (en) * | 1983-01-19 | 1985-09-10 | Datascope Corp. | Balloon catheter with intrinsic introducer for percutaneous insertion into a blood vessel over a guide wire, and method of use |
DE3347671A1 (en) * | 1983-12-31 | 1985-07-11 | Richard Wolf Gmbh, 7134 Knittlingen | TISSUE SAMPLING INSTRUMENT |
EP0150245A1 (en) * | 1984-01-30 | 1985-08-07 | Storz, Karl, Dr.med. h.c. | Endoscope for contact-viewing |
US5306244A (en) * | 1984-05-14 | 1994-04-26 | Surgical Systems & Instruments, Inc. | Method of guidewire insertion |
US4651753A (en) * | 1984-10-12 | 1987-03-24 | Jayco Pharmaceuticals | Endoscopic multiple biopsy instrument |
US4662870A (en) * | 1985-07-15 | 1987-05-05 | Augustine Scott D | Needle penetration indicator and guide |
US4791937A (en) * | 1986-08-19 | 1988-12-20 | Ko Pen Wang | Transendoscopic needle |
US4763667A (en) * | 1986-09-19 | 1988-08-16 | Microvasive, Inc. | Tissue-penetrating catheter device |
US5033477A (en) * | 1987-11-13 | 1991-07-23 | Thomas J. Fogarty | Method and apparatus for providing intrapericardial access and inserting intrapericardial electrodes |
US5053044A (en) * | 1988-01-11 | 1991-10-01 | Devices For Vascular Intervention, Inc. | Catheter and method for making intravascular incisions |
US4940468A (en) * | 1988-01-13 | 1990-07-10 | Petillo Phillip J | Apparatus for microsurgery |
US5387419A (en) * | 1988-03-31 | 1995-02-07 | The University Of Michigan | System for controlled release of antiarrhythmic agents |
US5702716A (en) * | 1988-10-03 | 1997-12-30 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
US4961729A (en) * | 1988-12-13 | 1990-10-09 | Vaillancourt Vincent L | Catheter insertion assembly |
USRE34086E (en) * | 1989-02-27 | 1992-10-06 | Medical placement device | |
US4991578A (en) * | 1989-04-04 | 1991-02-12 | Siemens-Pacesetter, Inc. | Method and system for implanting self-anchoring epicardial defibrillation electrodes |
US5071428A (en) * | 1989-09-08 | 1991-12-10 | Ventritex, Inc. | Method and apparatus for providing intrapericardial access and inserting intrapericardial electrodes |
US5295980A (en) * | 1989-10-30 | 1994-03-22 | Ersek Robert A | Multi-use cannula system |
US5019039A (en) * | 1989-11-15 | 1991-05-28 | Anderson Ronald W | Fluid drainage needle method of use |
US5366463A (en) * | 1990-05-02 | 1994-11-22 | Ryan William J | Atherectomy catheter for the removal of atherosclerosis from within blood vessels |
SE502055C2 (en) * | 1990-05-23 | 1995-07-31 | Atos Medical Ab | Device for applying a drainage duct |
US5195958A (en) * | 1990-05-25 | 1993-03-23 | Phillips Edward H | Tool for laparoscopic surgery |
AT397911B (en) * | 1990-07-04 | 1994-08-25 | Avl Verbrennungskraft Messtech | TWO TUMBLE NEEDLE FOR BODY LIQUIDS |
US5080663A (en) * | 1990-09-26 | 1992-01-14 | Univerity College London | Sewing device |
US5273530A (en) * | 1990-11-14 | 1993-12-28 | The University Of Rochester | Intraretinal delivery and withdrawal instruments |
US5213570A (en) * | 1990-12-14 | 1993-05-25 | Mallinckrodt Medical, Inc. | System and method for oxygenation of the pericardium |
US5249574A (en) * | 1991-01-15 | 1993-10-05 | Ventritex, Inc. | Implantation of leads |
US5071412A (en) * | 1991-03-01 | 1991-12-10 | Laparomed Corporation | Device and method for performing cholangiography |
DE4114311A1 (en) * | 1991-05-02 | 1992-11-12 | Harald Heidmueller | EXTRACTOR |
US5735290A (en) * | 1993-02-22 | 1998-04-07 | Heartport, Inc. | Methods and systems for performing thoracoscopic coronary bypass and other procedures |
US5235966A (en) * | 1991-10-17 | 1993-08-17 | Jay Jamner | Endoscopic retractor |
US5395312A (en) * | 1991-10-18 | 1995-03-07 | Desai; Ashvin | Surgical tool |
US5269326A (en) * | 1991-10-24 | 1993-12-14 | Georgetown University | Method for transvenously accessing the pericardial space via the right auricle for medical procedures |
US5336252A (en) * | 1992-06-22 | 1994-08-09 | Cohen Donald M | System and method for implanting cardiac electrical leads |
US5392765A (en) * | 1993-02-11 | 1995-02-28 | Circon Corporation | Continuous flow cystoscope |
JP2630197B2 (en) * | 1993-04-28 | 1997-07-16 | 株式会社ニッショー | Blood suction device |
US5381790A (en) * | 1993-06-23 | 1995-01-17 | Kanesaka; Nozomu | Electrophysiology apparatus |
US5385156A (en) * | 1993-08-27 | 1995-01-31 | Rose Health Care Systems | Diagnostic and treatment method for cardiac rupture and apparatus for performing the same |
US5366441A (en) * | 1993-09-28 | 1994-11-22 | Becton, Dickinson And Company | Catheter introducer assembly with guidewire |
GB9405790D0 (en) * | 1994-03-23 | 1994-05-11 | Univ London | Sewing device |
US5681278A (en) * | 1994-06-23 | 1997-10-28 | Cormedics Corp. | Coronary vasculature treatment method |
US5827216A (en) * | 1995-06-07 | 1998-10-27 | Cormedics Corp. | Method and apparatus for accessing the pericardial space |
WO1997016169A1 (en) * | 1995-11-01 | 1997-05-09 | Chiron Corporation | Treatment of a cardiovascular indication by delivery of therapeutics to the pericardial space |
US6059750A (en) * | 1996-08-01 | 2000-05-09 | Thomas J. Fogarty | Minimally invasive direct cardiac massage device and method |
US6206004B1 (en) * | 1996-12-06 | 2001-03-27 | Comedicus Incorporated | Treatment method via the pericardial space |
US5972013A (en) * | 1997-09-19 | 1999-10-26 | Comedicus Incorporated | Direct pericardial access device with deflecting mechanism and method |
US6231518B1 (en) * | 1998-05-26 | 2001-05-15 | Comedicus Incorporated | Intrapericardial electrophysiological procedures |
-
1995
- 1995-06-07 US US08/484,299 patent/US5827216A/en not_active Expired - Lifetime
-
1996
- 1996-06-07 CA CA002223954A patent/CA2223954C/en not_active Expired - Fee Related
- 1996-06-07 AU AU61799/96A patent/AU6179996A/en not_active Abandoned
- 1996-06-07 EP EP96919460A patent/EP0956094A4/en not_active Withdrawn
- 1996-06-07 JP JP50229697A patent/JP4005632B2/en not_active Expired - Fee Related
- 1996-06-07 WO PCT/US1996/010442 patent/WO1996040368A1/en active Application Filing
-
1998
- 1998-09-21 US US09/158,024 patent/US6162195A/en not_active Expired - Fee Related
-
2000
- 2000-07-26 US US09/625,900 patent/US6666844B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4005632B2 (en) | 2007-11-07 |
EP0956094A4 (en) | 2009-09-02 |
US6666844B1 (en) | 2003-12-23 |
CA2223954A1 (en) | 1996-12-19 |
US5827216A (en) | 1998-10-27 |
AU6179996A (en) | 1996-12-30 |
WO1996040368A1 (en) | 1996-12-19 |
EP0956094A1 (en) | 1999-11-17 |
US6162195A (en) | 2000-12-19 |
JP2001506869A (en) | 2001-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2223954C (en) | Method and apparatus for accessing the pericardial space | |
US20040167558A1 (en) | Method and apparatus for accessing the pericardial space | |
US6592552B1 (en) | Direct pericardial access device and method | |
US5972013A (en) | Direct pericardial access device with deflecting mechanism and method | |
US7207988B2 (en) | Method and apparatus for providing intra-pericardial access | |
US8876776B2 (en) | Engagement catheter systems and devices and methods of using the same | |
AU745717B2 (en) | Treatment method via the pericardial space | |
US20030093104A1 (en) | Methods and apparatus for providing intra-pericardial access | |
US8075532B2 (en) | Devices, systems, and methods for pericardial access | |
US9955999B2 (en) | Systems, devices, and methods for transeptal atrial puncture using an engagement catheter platform | |
US9050064B2 (en) | Systems for engaging a bodily tissue and methods of using the same | |
Macris et al. | Minimally invasive access of the normal pericardium: initial clinical experience with a novel device | |
WO1993015791A1 (en) | System for access to pericardial space | |
CA2684605C (en) | Devices, systems, and methods for pericardial access |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20140609 |